1

CURRICULUM VITAE Name: Raja Michael Flores, M.D. Place of Birth: New York, New York Nationality: American Office Address: Mount Sinai Health System One Gustave L. Levy Place Department of Thoracic Surgery, Box 1023 New York, New York 10029 Phone: (212) 241-9466 Fax: (646) 659-1521 E-Mail: raja.flores@mountsinai.org Licensed Physician: # 219223 9/14/00 New York Board Certification: #44459 9/15/99 American Board of Surgery #6504 6/08/01 American Board of Thoracic Surgery

Education: New York University 1984-1988, B.A. Biochemistry, New York, NY Albert Einstein College of Medicine 1988-1992, M.D., Bronx, NY Harvard University School of Public Health July 1 – August 15, 1997 Clinical Effectiveness Program, Boston, MA Columbia University School of Public Health 2001-2004, M.S. in Biostatistics (Clinical Research Methods), New York, NY

2

Postdoctoral Training: 1992 – 1993 General Surgery Internship Columbia Presbyterian Medical Center, New York, NY 1993 – 1997 General Surgery Residency Columbia Presbyterian Medical Center, New York, NY 1997 – 1998 Thoracic Oncology Clinical Research Fellowship

Intraoperative Chemotherapy, Mesothelioma, Lung Cancer, Clinical Trials Brigham and Women’s Hospital/ Dana Farber Cancer Institute/ CALGB, Boston, MA

1998-2000 Cardiothoracic Surgery Residency, Harvard Medical School,

Brigham and Women’s Hospital, Boston, MA

Positions and Appointments: 2001 – 2002 Clinical Assistant, Memorial Sloan-Kettering Cancer Center, New York, New York 2001 – 2002 Clinical Assistant Surgeon, Memorial Hospital, New York, New York 2002 – 2008 Assistant Member, Memorial Sloan-Kettering Cancer Center, New York, New York 2002 – 2008 Assistant Attending Surgeon, Memorial Hospital, ` New York, New York 2003 –2008 Assistant Professor of Cardiothoracic Surgery, Weill College, Cornell University, New York, New York 2008 – 2010 Associate Member, Memorial Sloan-Kettering Cancer Center, New York, New York 2008 – 2010 Associate Attending Surgeon, Memorial Sloan-Kettering Cancer Center, New York, New York 2008 – 2010 Associate Professor of Cardiothoracic Surgery, Weill College, Cornell University, New York, New York

3

2010 – Present Chief, Division of Thoracic Surgery

Mount Sinai Medical Center, New York, New York 2010 – Present Steven and Ann Ames Professor of Thoracic Surgery Endowed Chair in Thoracic Surgery Icahn School of Medicine at Mount Sinai, New York, New York 2014 - Present Chairman (founding Chair 2014) of the newly created Department of Thoracic Surgery Icahn School of Medicine at Mount Sinai, New York, New York 2014 – 2019 Attending Surgery, Department of Surgery James J. Peters VA Medical Center, Department of Veterans Affairs Medical Center, Bronx, New York 2017 – Present Honorary Police Surgeon, Police Department City of New York,

New York Scientific and Medical Societies: American Association of Thoracic Surgeons American College of Chest Physicians American College of Surgeons Oncology Group American College of Surgeons American Medical Association American Society of Clinical Oncology American Thoracic Society Asociacion Iberoamericana de Cirugia Toracica Cancer and Leukemia Group B European Association for Cardio-Thoracic Surgery General Thoracic Surgical Club International Association for the Study of Lung Cancer (IASLC) International Early Lung Cancer Action Project (I-ELCAP) International Society for Minimally Invasive Cardiothoracic Surgery Lung Cancer Alliance Medical Society State of New York National Hispanic Medical Association The New York Academy of Medicine New York County Medical Society New York Society of Physicians Sociedad Mexicana de Cirujanos Torácicos Generales

4

Scientific and Medical Societies: (continued) The Society for Surgery of the Alimentary Tract Society of Brigham Surgical Alumni Society of Laparoendoscopic Surgeons Society of Surgical Oncology Society of Thoracic Surgeons Administrative Committees: Mount Sinai Health System: Medical Board, Mount Sinai Health System – Member 5/2014-PRESENT Association of the Attending Staff – Member 5/2014-PRESENT Clinical Integration Advisory Committee - Member 6/2014-PRESENT Cancer Steering Committing, Mount Sinai Health System – Member 6/2014-PRESENT CEYE Advisory Council Meeting – Member 6/2014-PRESENT Dean’s Clinical Leadership Meeting – Member 6/2014-PRESENT Memorial Sloan-Kettering Cancer Center: MSKCC Department of Surgery Protocol Review Committee 2001-2007 MSKCC Cardiac Care Committee 2005-2007 Memorial Hospital Alumni Society Officers – Member 2006-2007 Memorial Hospital Alumni Society – Treasurer 2008 Memorial Hospital Alumni Society – Vice President 2009 Memorial Hospital Alumni Society – President 2010 Societies: New York County Medical Society, Committee on 2007

Government Affairs - Member European Society of Thoracic Surgeons 2008-PRESENT Adhoc Committee Technological Advancement Evarts A. Graham Memorial Traveling Fellowship Committee 2009-2012 American Association for Thoracic Surgery (AATS) Chair, Evarts A. Graham Memorial Traveling Fellowship American Association for Thoracic Surgery 2012-2013 The Society of Thoracic Surgeons, Leader, Workforce on New Technology 2011-2015 Asbestos Disease Awareness Organization Science Advisory Board, 2016 Asbestos Disease Awareness Organization (ADAO) The International Association for the Study of Lung Cancer 2016 Mesothelioma Task Force Co-Chair, Mount Sinai Adolescent Health Center 15th Annual 2018 Breakfast of Legends Boards: New York University (NYU) Arts and Science FAS Board of Overseers 2017-PRESENT

5

Education: Cornell University Medical College Admissions Committee 2002-2010 Board of Governors, Alumni Association Albert Einstein College of Medicine 2011-PRESENT FAS Board of Overseers, New York University 2018 Teaching: Course Director: Multimodality Treatment of Gastric and Esophageal Malignancies. Memorial Sloan-Kettering Cancer Center, New York, NY, 11/18-19/10 Course Director: Lung Cancer Screening: A Paradigm Shift in Primary Care. One-Day Intensive Course. Mount Sinai Medical Center, New York, NY, 5/11/13 Course Director: Integrating CT Screening for Lung Cancer into Everyday Practice: A One-Day Intensive Course for Practicing Clinicians. Mount Sinai Medical Center, New York, NY, 4/5/14 Course Director: Integrating 20 Years’ Experience In CT Screening For Lung Cancer Into Everyday Practice: An International Two-Day Intensive Course For Practicing Clinicians, New York Academy of Medicine, New York, NY, 12/5-6/14. Course Director: I-ELCART Advances in Early Detection, Diagnosis, and Treatment of Lung Cancer: Integrating New Paradigms of Assessment and 25 Years of Research and Experience 1st International Conference On Early Lung Cancer Treatment, Icahn School of Medicine at Mount Sinai, New York, NY, 12/4-5/15 Course Director: Lung Cancer Screening Program in Brooklyn, Mount Sinai of Brooklyn, Brooklyn, NY, 6/6/16 Awards: Dr. Irving Selikoff Lifetime Achievement Award April 8, 2017 13th Annual International ADAO Asbestos Awareness

and Prevention Conference Live Surgical Performance: 2nd Asian-Pacific VATS Lobectomy Guangzhou, China. June 25, 2011. Centro Nacional deCirugia de Minimo Acceso, Havana, Cuba, February 25, 2013. Instituto de Medicina Tropical Pedro Kouri, Havana, Cuba, February 4-6, 2014. Hospital 10 de Octubre Havana, Cuba, March 2-3, 2015. Instituto Nacional de Cancerologia, Master Class. Tlalpan, Ciudad De Mexico, November 5-6, 2018.

6

Trainees - 2 year thoracic fellowship

Name Year Current Position Modesto Colon 2013-2015 Banner Estrella Medical Ct AZ

William Gioia (Chief) 2017-2019 Mount Sinai Health System NY Brian Housman 2018-2020 Mount Sinai Health System NY Dong-Seok Lee 2009-2011 Mount Sinai Health System NY Frederico Milla 2008-2010 Piedmont Hospital GA Vicente Orozco 2012-2014 Mount Sinai Health System NY Mark Shapiro 2011-2013 Blumenthal Cancer Center NJ Mitsuko Takahashi 2010-2012 Jefferson Hospital PA Madhuri Rao 2014-2016 University of Minnesota MN Trainees - Non-accredited thoracic surgery fellowship program

Name Year Current Position

Daniel Fink 2012-2013 Shaare Zedek Medical Center Israel Ardeshir Hakami 2010-2011 Mount Sinai Health System NY James Lim 2012-2013 Columbia Presbyterian Hospital NY Daniel Nicastri 2011 Mount Sinai Health System NY Geoffrey Pelz 2012-2013 Hackensack UMC NJ Cesar Calderon 2015-2016 Univ Hospital Gran Canaria Dr Spain

A Tantraworsain 2015-2016 Mount Sinai Health System NY Robert Sweeney 2018-2021 Mount Sinai Health System NY Trainees - Integrated 6-year Residency in cardiovascular and thoracic surgery

Name Year Sophie Alexis 2018-2024 PGY 1

Javier Castillo 2010-2016 PGY 6 NY Lilyanne Chen 2018-2022 PGY 2

Ana Claudia Costa 2015-2021 PGY 4 Shinobu Itagaki 2013-2019 Post PGY 6 Aarti Patil 2018-2021 PGY 3

Amit Pawale 2010-2016 PGY 6 Aditya Sengupta 2018-2024 PGY 1

Stephen Spindel 2012-2018 PGY 4 Nana Toyoda 2018-2022 PGY 2

Aaron Weiss 2011-2015 Post PGY 6 Elbert Williams 2014-2020 PGY 5 Maroun Yammine 2018-2021 PGY 3

7

Journals Reviewer for: Head & Neck 2003 - present Journal of Thoracic and Cardiovascular Surgery 2004 – present Editorial Board Journal of Thoracic Oncology 2005 - present Lung Cancer 2006 - present Journal of Clinical Oncology 2006 - present Annals of Surgical Oncology 2007 - present British Journal of Cancer 2008 - present Annals of Thoracic Surgery 2008 - present Chemotherapy 2007 - present Chest 2004 - present Journal of Respiratory Diseases 2008 - present Hospital Physician Pulmonary Disease Board Review Manual 2008 - present Clinical Cancer Research 2008 - present Southern Medical Journal 2009 - present Saudi Medical Journal 2009 - present Cancer 2009 - present Molecular Cancer 2009 - present Archives of Internal Medicine 2009 - present European Journal of Cardio-thoracic Surgery & Interactive 2009 - present CardioVascular and Thoracic Surgery 2010 - present THORAX: An international journal of respiratory medicine 2010 - present The European Journal of Clinical & Medical Oncology 2010 - present Journal of Cardiovascular Surgery 2015 - present POS One 2015 - present Journal Clinics in Oncology - Thoracic Oncology 2016 - present Journal Clinics in Surgery - Thoracic Surgery 2016 - present Editorial Board Journal of Thoracic Diseases – Editorial Board 2016 - present Annals of Translational Medicine – Editorial Board 2017 - 2019 Languages: Spoken: English, Spanish, Arabic Written: English, Spanish

8

Research The Department of Thoracic Surgery at the Icahn School of Medicine at Mount Sinai is committed to enhancing diagnostics and treatment capabilities for malignant diseases of the lungs, esophagus, mediastinum, and chest wall. Our department is skilled in a number of cutting-edge treatments—including minimally invasive surgery. Our current research initiatives are focused on improving patient care within the following areas: Center of the Study of Thoracic Diseases The mission of the Center is to advance the diagnosis and treatment of congenital, acquired and malignant diseases of the lungs, esophagus, mediastinum, and chest wall, reduce health disparities and improve access to surgical care. Faculty provides leading-edge treatments including minimally invasive surgery but at the same time strives to further improve patient care through basic science, epidemiologic, and clinical research in areas such as the following: Lung Cancer We are conducting an array of research studies and clinical trials to improve upon both the diagnosis and treatment of lung cancer. Areas of focus include the Lung Cancer Early Detection Program. The program includes a smoking cessation study, basic science studies that examine biological indicators of aggressive early-stage lung cancer, and immune-fighting cells in the lung. We are also looking at lung cancer disparities correlating to access to care as part of research on quality of life after surgery. Second Primary Cancers Program Our department is committed to studying the best treatment strategies for patients who present with a second thoracic cancer after having successfully treated the first cancer. We have shown in our studies that surgery is the best treatment option for subsequent cancers. Mesothelioma Program The Thoracic Surgery Translational Laboratory is working to identify the key proteins and important pathways involved in this form of cancer. Our investigators are developing novel tests to determine which mesothelioma tumors have abnormal transcription factor activity, and designing drug therapies intended to inhibit these factors. Efforts to identify biological differences responsible for gender differences in mesothelioma outcome, with the ultimate purpose of identifying molecular targets for new therapeutic agents are included in this program. We have partnered with an internationally renowned group to identify and validate novel germline DNA variants associated with increased risk of asbestos-induced malignant pleural mesothelioma (MPM) (Collaborator-Carbone). In an effort to develop novel chemotherapeutic agents for MPM, we have identified––through drug repurposing approach––two compounds that show anti-MPM activity. Efforts are underway to validate these compounds.

9

Libby Epidemiology Research Project We received a $4.8 million RO1 grant, funded by the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. As Principal Investigator I traveled to Libby, Montana frequently and examined the health impact of asbestos exposure. Our researchers investigated the disease pathology from the town of Libby, Montana, with the goals of assessing risks of exposure to asbestos during childhood; examining the relationships between mesothelioma, lung cancer, autoimmune disorders, autoimmune antibody abnormalities, and CT-scan evidence of related scarring lung disease; and recommended environmental cleanup efforts. Thymoma The effect on survival and quality of life of surgical treatment of thymoma is being studied by our department. Various surgical techniques are examined using large data sets such as Statewide Planning and Research Cooperative System (SPARCS) data, and meta-analytic techniques. Esophageal cancer Some of our researchers are studying survival rates of esophageal cancer – related to type of treatment, access to proper care, and quality of health care delivery in different ethnic groups using administrative data sets from the Agency for Healthcare Research and Quality (AHRQ). Personalized and Targeted Therapy Research at the Thoracic Surgery Translational Laboratory is focused on developing personalized therapies for a range of thoracic malignancies. Current efforts include work to identify and design novel small molecule inhibitors for the treatment of drug resistant cancers. Using the publically available genomic data, we are trying to understand the molecular mechanisms of progression to clinically significant lung cancer. Driven by the hypothesis that the aggressiveness of lung adenocarcinoma is associated with distinct gene signatures, we have identified a set of genes over expressed in these cancers. Through an IRB approved protocol, we are currently validating our computational findings (Collaborator-Reva). Myeloid suppressor cells (MDSC) and Tumor-Associated macrophages (TAM) are responsible for supporting an environment that promotes lung cancer progression and immune escape. Our project goal is to understand the modulation of MDSC and TAM functions. Results from this study will be used to better design MDSC/TAM-targeted therapies that may improve Lung cancer immunotherapeutic drug efficacy. Airway Research Laboratory The overarching theme of the Thoracic Surgery Research Laboratory is to bioengineer a viable human trachea using tools of regenerative medicine, 3D printing and stem cells. Pathologies of the trachea can have life-limiting or -devastating events. Patients with long segment airway stenosis secondary to prolonged intubation, severe airway inhalation injuries or cancer lesions, often undergo multiple surgeries or procedures. To date, there is no suitable conduit that can effectively replace a tracheal segment with safety and restore adequate airway function and dynamics. Using advanced imaging and CAD tools, we can pre-correct tracheal anatomy and customize a 3D printed trachea to fit and replace the segment of interest. We have successfully transplanted more than a dozen of bioengineered partial tracheal constructs in a large animal model, and are actively pursuing to translate this research into a lifesaving procedure.

10

Biobank The Center has established a bank of surgical cancer tissues and blood linked to clinical and follow-up data, in collaboration with Pathology. Immunotherapy We have an ongoing collaboration with the Cancer Immunology Immunotherapy Program/Human Immuno-monitoring center at The Tisch Cancer Institute. In close collaboration with its Director, Dr Miriam Merad, we are conducting several translational studies on lung cancer. One of the studies involves detecting in surgical lung specimens immunological patterns in the tumor microenvironment that predict lung cancer aggressiveness. Up to now we have analyzed 21 fresh tissues and are now collecting follow-up data to assess recurrence and mortality. The ultimate goal is to develop a unique biomarker panel that could be used at surgery to guide the extent of treatment. Through the collaboration with the Epidemiology group (Dr. Taioli) we are also testing the same biomarker panel in biopsies from the lung cancer early detection screening program (Dr. Henschke). Another planned study with the Immunotherapy group is a clinical trial involving lung cancer local treatment with novel immunotherapy during surgery. We are also conducting a meta-analysis in collaboration with Drs. Taioli and Merad on tumor microenvironment immunoresponse and lung cancer mortality.

11

Grants: Title: Comparative Effectiveness of Limited Resection vs. Stereotactic Body Radiation Therapy for Early Stage Lung Cancer Principal Investigator: Juan Wisnivesky Co-Investigator: Raja M. Flores Funding Agency: NIH/NCI R01CA203193 $492,186 3/1/162/28/21 Title: National Mesothelioma Virtual Bank Expansion: The "SPIRiT of Collaboration” (U24OH009077-06 CDC Resource-Related Research Project - Cooperative Agreement; translational research of mesothelioma) Principal Investigator: Becich Site Principal Investigator: Raja M. Flores Funding Agency: NIH/CDC U24OH009077-06 $1,084,334 09/01/1108/31/16 Title: Correlation of Body Fluids (urine/blood) with the Molecular Characteristics in Lung Tumor Tissue Specimens Principal Investigator: Raja M. Flores Funding Agency: Exosome Diagnostics, Inc. 7/16/128/31/17 Title: Libby Epidemiology Research Program Principal Investigator: Raja M. Flores Funding Agency: NIH/CDC/ATSDR RO1TS000099 - ATSDR TS09-001 $4,800,000 9/30/109/29/15 Title: Early Detection of Esophageal Adenocarcinoma Using Targeted Fluorescent Imaging Principal Investigator: Sharmila Anandasabapathy Co-Investigator: Raja M. Flores Funding Agency: Esophageal Cancer Education Foundation Grant#09-0223-00002-01 $30,000 09/01/201208/31/2013 Title: A Phase II Trial of Induction Chemotherapy, Surgical Resection, and Adjuvant External Beam Radiation for Locally Advanced Malignant Pleural Mesothelioma Principal Investigator: Raja M. Flores Funding Agency: Lilly Research Laboratories, Investigational New Drug Application, Protocol No. B9E-MC-X294, $135,000 20012004. Title: Wake Health Consortium for the Sharing of Germ line DNA and Tissues from Subjects with Mesothelioma Principal Investigator: Raja Flores Funding Agency: Mesothelioma Applied Research Foundation (MARF) 04/26/2012—04/25/2013

12

Title: Characterization of Dendritic Cell Alterations in Sarcoidosis Principal Investigator: Miriam Merad Other Significant Investigator: Raja M. Flores Funding Agency: Stony Wold-Herbert Fund, Inc. 2011 Submitted Grants Title: Does Libby Amphibole Contribute to World Trade Center Disease? Principal Investigator: Raja M. Flores Funding Agency: NIOSH/CDC/DHHS $499,997 UO1 0H010999 (Scored 56 but not funded; resubmitted) Title: Cohort of Lung Cancer Screening Participants (CLuSP) Principal Investigator: Raja M. Flores Funding Agency: NIH/NCI $795,361 U01CA209567 (Scored 45 but not funded; resubmitted) Projects: Icahn School of Medicine at Mount Sinai: Title: Evaluate expression of PP2A tumor suppressor in a cohort of lung adenocarcinoma tumor specimens and to correlate expression with survival as well as KRAS mutation status (ID# IF1782454) Principal Investigator: Raja M. Flores 10/29/201510/28/2016 Title: Phase II Toxicity Study Using Chemotherapy Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients with Locally Advanced Malignant Pleural Mesothelioma (ID# IF 1235644) Co-Investigator: Raja M. Flores 2012 Title: Histological Subtypes of Mesothelioma and Long-Term Survival (ID#: IF1307938) Principal Investigator: Raja M. Flores 06/06/201106/05/2015 Title: Survival Comparison between VATS Segmentectomy and VATS Lobectomy in Patients with Stage I Lung Cancer (ID#: IF1322786) Principal Investigator: Raja M. Flores 08/26/201108/25/2012 Title: The Role of Subcarinal Lymph Nodes during Upper Lobectomy for Clinical Early Non-Small Cell Lung Cancer (ID#: IF1288418) Principal Investigator: Raja M. Flores 2011

13

Title: Mount Sinai Cancer Center Biorepository (ID#: IF1349334) Principal Investigator: Raja M. Flores 01/01/2011Indefinitely Title: Characterization of Dendritic Cell Subsets in the Healthy and Diseased Human Lung (ID#: IF1351204) Principal Investigator: Christian D. Becker Significant Investigator: Raja M. Flores 11/24/2008-11/23/2012 Title: Fine Needle Aspiration (FNA) Biopsy Registry (ID#: IF1325448) Principal Investigator: David F. Yankelevitz Co-Investigator: Raja M. Flores 01/01/2011Indefinitely Memorial Sloan-Kettering Cancer Center: Title: A Phase II Trial of Induction Chemotherapy, Surgical Resection, and Adjuvant External Beam Radiation for Locally Advanced Malignant Pleural Mesothelioma Principal Investigator: Raja M. Flores Funding Agency: Lilly Research Laboratories, Investigational New Drug Application, Protocol No. B9E-MC-X294, $135,000, 20012004. Title: The Role of Laparoscopic Staging in Patients with Resectable Gastroesophageal Junction Carcinomas Principal Investigator: Raja M. Flores Funding Agency: Memorial Sloan-Kettering Cancer Center 20002002 Title: A Randomized Phase III Trial Surgery Alone or Surgery Plus Preoperative Paclitaxel/Carboplatin in Clinical Stage IB (T2N0), II (T1-2N1, T3N0) and selected IIIA None Small Cell Lung Cancer (NSCLC) – (RTOGL-0015 (S9900) Site Principal Investigator: Raja M. Flores Funding Agency: Memorial Sloan-Kettering Cancer Center 20002002 Title: Randomized, Prospective Trial of Mediastinal LN Sampling Vs. Complete Lymphadenectomy During Conduct of Pulmonary Resection in Patients with N0 and N1 (less than hilar) non-small cell carcinoma (ACOSOG Z0030) Site Principal Investigator: Raja M. Flores Funding Agency: Memorial Sloan-Kettering Cancer Center 1999-2000 Brigham and Women’s Hospital: Title: Extrapleural Pneumonectomy Followed by Intrathoracic/Intraperitoneal Heated Cisplatin and Intravenous Sodium Thiosulfate in the Multimodality Treatment of Malignant Pleural Mesothelioma: A Phase I Study Co-Principal Investigator: Raja M. Flores Funding Agency: Brigham and Women’s Hospital, Boston, MA 19971999

14

Peer-Reviewed Publications

1. Goldstein DJ, Flores RM, Todd GJ. Rupture of a nonaneurysmal atherosclerotic infrarenal aorta. J Vasc Surg. 1997 Oct;26(4):700-3. PubMed PMID: 9357475.

2. Flores RM, Goldstein DJ, Sung RS, Steinglass KM, Weinstein S, et al. Transthoracic, transdiaphragmatic excision of simultaneous lung and adrenal lesions. Ann Thorac Surg. 1998 Mar;65(3):833-5. PubMed PMID: 9527227.

3. Flores RM, Jaklitsch MT, DeCamp MM Jr, Sugarbaker DJ. Video-assisted thoracic surgery pericardial resection for effusive disease. Chest Surg Clin N Am. 1998 Nov;8(4):835-51. PubMed PMID: 9917928.

4. Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999 Jan;117(1):54-63; discussion 63-5. PubMed PMID: 9869758.

5. Rabkin DG, Goldstein DJ, Flores RM, Benvenisty AI. Spontaneous popliteal artery dissection: a case report and review of the literature. J Vasc Surg. 1999 Apr;29(4):737-40. PubMed PMID: 10194508.

6. Flores RM, Sugarbaker DJ. High-risk bronchoscopy. Ann Thorac Surg. 2000 May;69(5):1604-5. PubMed PMID: 10881862.

7. Flores RM, Sugarbaker DJ. Malignant mesothelioma of the pleural space. Ann Thorac Surg. 2000 Jul;70(1):306. PubMed PMID: 10921738.

8. Caiati JM, Marin ML, Flores RM, Smith CR, Martin EC, et al. Endovascular management of an aortobronchial fistula arising after resection of a primary aortic sarcoma: a case report. Vasc Surg. 2001 Jan-Feb;35(1):73-9. PubMed PMID: 11668373.

9. Flores RM, Byrne JG. Aortic valve replacement with an anomalous left circumflex coronary artery encircling the aortic anulus. J Thorac Cardiovasc Surg. 2001 Feb;121(2):396-7. PubMed PMID: 11174751.

10. Flores RM, Murthy S, DeCamp MM Jr. Contralateral pulmonary artery stenosis after left pneumonectomy. Ann Thorac Surg. 2001 Jul;72(1):274-6. PubMed PMID: 11465201.

11. Flores RM, Rusch VW. Commentary: Zellos LS, Sugarbaker DJ. Diffuse malignant mesothelioma of the pleural space and its management. Oncology (Williston Park). 2002 Jul;16(7):907-13; discussion 916-7, 919-20, 925. PubMed PMID: 12164558

12. Flores RM, Akhurst T, Gonen M, Larson SM, Rusch VW. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural

15

mesothelioma. J Thorac Cardiovasc Surg. 2003 Jul;126(1):11-6. PubMed PMID: 12878934.

13. Yajnik S, Rosenzweig KE, Mychalczak B, Krug L, Flores R, et al. Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1319-26. PubMed PMID: 12873676.

14. Park BJ, Flores R, Downey RJ, Bains MS, Rusch VW. Management of major hemorrhage during mediastinoscopy. J Thorac Cardiovasc Surg. 2003 Sep;126(3):726-31. PubMed PMID: 14502145.

15. Giusti RJ, Flores RM. Mucoepidermoid carcinoma of the bronchus presenting with a negative chest X-ray and normal pulmonary function in two teenagers: two case reports and review of the literature. Pediatr Pulmonol. 2004 Jan;37(1):81-4. PubMed PMID: 14679495.

16. Weyant MJ, Flores RM. Imaging of pleural and chest wall tumors. Thorac Surg Clin. 2004 Feb;14(1):15-23. PubMed PMID: 15382305.

17. Chi DS, Abu-Rustum NR, Sonoda Y, Chen SW, Flores RM, et al. The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions. Gynecol Oncol. 2004 Aug;94(2):307-11. PubMed PMID: 15297166.

18. Park BJ, Bacchetta M, Bains MS, Downey RJ, Flores R, et al. Surgical management of thoracic malignancies invading the heart or great vessels. Ann Thorac Surg. 2004 Sep;78(3):1024-30. PubMed PMID: 15337042.

19. Flores RM. Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience. Lung Cancer. 2005 Jul;49 Suppl 1:S71-4. PubMed PMID: 15950805.

20. Flores RM. The role of PET in the surgical management of malignant pleural mesothelioma. Lung Cancer. 2005 Jul;49 Suppl 1:S27-32. PubMed PMID: 15950796.

21. Gupta V, Mychalczak B, Krug L, Flores R, Bains M, et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1045-52. PubMed PMID: 16054774.

22. Park BJ, Flores RM, Rusch VW. Robotic assistance for video-assisted thoracic surgical lobectomy: technique and initial results. J Thorac Cardiovasc Surg. 2006 Jan;131(1):54-9. PubMed PMID: 16399294.

23. Weyant MJ, Bains MS, Venkatraman E, Downey RJ, Park BJ, et al. Results of chest wall resection and reconstruction with and without rigid prosthesis. Ann Thorac Surg. 2006 Jan;81(1):279-85. PubMed PMID: 16368380.

16

24. Juretzka MM, Horton FR, Abu-Rustum NR, Sonoda Y, Jarnagin WR, et al. Full-thickness diaphragmatic resection for stage IV ovarian carcinoma using the EndoGIA stapling device followed by diaphragmatic reconstruction using a Gore-tex graft: a case report and review of the literature. Gynecol Oncol. 2006 Mar;100(3):618-20. PubMed PMID: 16226799.

25. López-Ríos F, Chuai S, Flores R, Shimizu S, Ohno T, et al. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Res. 2006 Mar 15;66(6):2970-9. PubMed PMID: 16540645.

26. Flores RM, Krug LM, Rosenzweig KE, Venkatraman E, Vincent A, et al. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. J Thorac Oncol. 2006 May;1(4):289-95. PubMed PMID: 17409872.

27. Park BJ, Carrasquillo J, Bains MS, Flores RM. Giant benign esophageal schwannoma requiring esophagectomy. Ann Thorac Surg. 2006 Jul;82(1):340-2. PubMed PMID: 16798252.

28. dos Santos LA, Modica I, Flores RM, D'Angelica M, Aghajanian C, et al. En bloc resection of diaphragm with lung for recurrent ovarian cancer: a case report. Gynecol Oncol. 2006 Sep;102(3):596-8. PubMed PMID: 16782176.

29. Flores RM, Su W, Lal D, Rusch VW, La Quaglia MP. Extrapleural pneumonectomy in children. J Pediatr Surg. 2006 Oct;41(10):1738-42. PubMed PMID: 17011280.

30. Flores RM, Akhurst T, Gonen M, Zakowski M, Dycoco J, et al. Positron emission tomography predicts survival in malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2006 Oct;132(4):763-8. PubMed PMID: 17000285.

31. Garcia A, Flores RM, Schattner M, Kraus D, Bains MS, et al. Endoscopic retrograde dilation of completely occlusive esophageal strictures. Ann Thorac Surg. 2006 Oct;82(4):1240-3. PubMed PMID: 16996914.

32. Rizk N, Venkatraman E, Park B, Flores R, Bains MS, et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg. 2006 Dec;132(6):1374-81. PubMed PMID: 17140960.

33. Moskovitz AH, Rizk NP, Venkatraman E, Bains MS, Flores RM, et al. Mortality increases for octogenarians undergoing esophagogastrectomy for esophageal cancer. Ann Thorac Surg. 2006 Dec;82(6):2031-6; discussion 2036. PubMed PMID: 17126106.

34. Rizk NP, Venkatraman E, Bains MS, Park B, Flores R, et al. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving

17

multimodality therapy for esophageal adenocarcinoma. J Clin Oncol. 2007 Feb 10;25(5):507-12. PubMed PMID: 17290058.

35. Flores RM, Alam N. Treatment of malignant pleural mesothelioma: Pleurectomy with adjuvant therapy. Operative Techniques in Thoracic and Cardiovascular Surgery. 2006 Volume 11(1):57-55

36. Juretzka MM, Abu-Rustum NR, Sonoda Y, Downey RJ, Flores RM, et al. The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusions. Gynecol Oncol. 2007 Mar;104(3):670-4. PubMed PMID: 17150248.

37. Alam N, Flores RM. Video-assisted thoracic surgery (VATS) lobectomy: the evidence base. JSLS. 2007 Jul-Sep;11(3):368-74. PubMed PMID: 17931521; PubMed Central PMCID: PMC3015831.

38. Wartmann CT, Morris CD, Latmore M, Flores RM. Aneurysmal sternal bone cyst: a novel treatment method. J Thorac Cardiovasc Surg. 2007 Aug;134(2):533-4. PubMed PMID: 17662814.

39. Flores RM, Zakowski M, Venkatraman E, Krug L, Rosenzweig K, et al. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thorac Oncol. 2007 Oct;2(10):957-65. PubMed PMID: 17909360.

40. Wartmann CT, Fernandez D, Flores RM. Fibroepithelial polyps: preoperative diagnosis may avoid thoracotomy. J Thorac Cardiovasc Surg. 2007 Oct;134(4):1080-1. PubMed PMID: 17903549.

41. Alam N, Park BJ, Wilton A, Seshan VE, Bains MS, et al. Incidence and risk factors for lung injury after lung cancer resection. Ann Thorac Surg. 2007 Oct;84(4):1085-91; discussion 1091. PubMed PMID: 17888952.

42. Carbone M, Albelda SM, Broaddus VC, Flores RM, Hillerdal G, et al. Eighth international mesothelioma interest group. Oncogene. 2007 Oct 25;26(49):6959-67. PubMed PMID: 17496929.

43. Huang J, Rizk NP, Travis WD, Seshan VE, Bains MS, et al. Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg. 2007 Dec;134(6):1477-83; discussion 1483-4. PubMed PMID: 18023668.

44. Cattaneo SM, Park BJ, Wilton AS, Seshan VE, Bains MS, et al. Use of video-assisted thoracic surgery for lobectomy in the elderly results in fewer complications. Ann Thorac Surg. 2008 Jan;85(1):231-5; discussion 235-6. PubMed PMID: 18154816.

18

45. Flores RM, Alam N. Video-assisted thoracic surgery lobectomy (VATS), open thoracotomy, and the robot for lung cancer. Ann Thorac Surg. 2008 Feb;85(2):S710-5. PubMed PMID: 18222202.

46. Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg. 2008 Mar;135(3):620-6, 626.e1-3. PubMed PMID: 18329481.

47. Garcia A, Flores RM. Surgical management of tumors invading the superior vena cava. Ann Thorac Surg. 2008 Jun;85(6):2144-6. PubMed PMID: 18498851.

48. Orlow I, Park BJ, Mujumdar U, Patel H, Siu-Lau P, et al. DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumors. J Clin Oncol. 2008 Jul 20;26(21):3560-6. PubMed PMID: 18640936; NIHMSID: NIHMS656956; PubMed Central PMCID: PMC4423737.

49. Park BJ, Flores RM. Cost comparison of robotic, video-assisted thoracic surgery and thoracotomy approaches to pulmonary lobectomy. Thorac Surg Clin. 2008 Aug;18(3):297-300, vii. PubMed PMID: 18831506.

50. Kent M, Rice D, Flores R. Diagnosis, staging, and surgical treatment of malignant pleural mesothelioma. Curr Treat Options Oncol. 2008 Jun;9(2-3):158-70. PubMed PMID: 18758965.

51. Flores RM, Routledge T, Seshan VE, Dycoco J, Zakowski M, et al. The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg. 2008 Sep;136(3):605-10. PubMed PMID: 18805259.

52. Garcia A, Byrne JG, Bueno R, Flores RM. Aneurysm of the main pulmonary artery. Ann Thorac Cardiovasc Surg. 2008 Dec;14(6):399-401. PubMed PMID: 19131930.

53. Deng G, Rusch V, Vickers A, Malhotra V, Ginex P, et al. Randomized controlled trial of a special acupuncture technique for pain after thoracotomy. J Thorac Cardiovasc Surg. 2008 Dec;136(6):1464-9. PubMed PMID: 19114190; NIHMSID: NIHMS85307; PubMed Central PMCID: PMC2633643.

54. Onaitis MW, Petersen RP, Haney JC, Saltz L, Park B, et al. Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases. Ann Thorac Surg. 2009 Jun;87(6):1684-8. PubMed PMID: 19463577.

19

55. Gupta V, Krug LM, Laser B, Hudka K, Flores R, et al. Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumonectomy and photon-electron radiotherapy. J Thorac Oncol. 2009 Jun;4(6):746-50. PubMed PMID: 19404212.

56. Krug LM, Pass HI, Rusch VW, Kindler HL, Sugarbaker DJ, et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol. 2009 Jun 20;27(18):3007-13. PubMed PMID: 19364962; PubMed Central PMCID: PMC3646305.

57. Flores RM. Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication. Semin Thorac Cardiovasc Surg. 2009 Summer;21(2):149-53. PubMed PMID: 19822286.

58. Huang J, Rizk NP, Travis WD, Riely GJ, Park BJ, et al. Comparison of patterns of relapse in thymic carcinoma and thymoma. J Thorac Cardiovasc Surg. 2009 Jul;138(1):26-31. PubMed PMID: 19577051; NIHMSID: NIHMS460243; PubMed Central PMCID: PMC4151511.

59. Flores RM, Park BJ, Dycoco J, Aronova A, Hirth Y, et al. Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer. J Thorac Cardiovasc Surg. 2009 Jul;138(1):11-8. PubMed PMID: 19577048.

60. Finley DJ, Abu-Rustum NR, Chi DS, Flores R. Reconstructive techniques after diaphragm resection. Thorac Surg Clin. 2009 Nov;19(4):531-5. PubMed PMID: 20112636.

61. Flores RM. Invited commentary. Factors associated with postoperative symptoms after laparoscopic Heller myotomy. Ann Thorac Surg. 2010 Feb;89(2):396. doi: 10.1016/j.athoracsur.2009.11.040. PubMed PMID: 20103307.

62. Rai AJ, Flores RM, Mathew A, Gonzalez-Espinoza R, Bott M, et al. Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels. Clin Chem Lab Med. 2010 Feb;48(2):271-8. PubMed PMID: 20131968.

63. Finley DJ, Yoshizawa A, Travis W, Zhou Q, Seshan VE, et al. Predictors of outcomes after surgical treatment of synchronous primary lung cancers. J Thorac Oncol. 2010 Feb;5(2):197-205. PubMed PMID: 20101145.

64. Blasberg JD, Pass HI, Goparaju CM, Flores RM, Lee S, et al. Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer. J Clin Oncol. 2010 Feb 20;28(6):936-41. PubMed PMID: 20085934; PubMed Central PMCID: PMC2834433.

65. Diaz JP, Abu-Rustum NR, Sonoda Y, Downey RJ, Park BJ, et al. Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced

20

ovarian carcinoma can influence the primary management choice for these patients. Gynecol Oncol. 2010 Mar;116(3):483-8. PubMed PMID: 19945741.

66. Flores RM. Video-assisted thoracic surgery (VATS) lobectomy: focus on technique. World J Surg. 2010 Apr;34(4):616-20. PubMed PMID: 20082195.

67. Liu F, Zhao B, Krug LM, Ishill NM, Lim RC, et al. Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scans. J Thorac Oncol. 2010 Jun;5(6):879-84. PubMed PMID: 20421814.

68. Ihekweazu UN, Travis WD, Flores RM. Is pneumonectomy mandatory after transection of the left main pulmonary artery?. J Thorac Cardiovasc Surg. 2010 Jul;140(1):242-3. PubMed PMID: 19783015.

69. Ihekweazu UN, Ludwig E, Flores RM. PillCam in gastric conduit after Ivor Lewis esophagectomy. Ann Thorac Surg. 2010 Aug;90(2):673. PubMed PMID: 20667385.

70. Abbey AM, Flores RM. Spontaneous resolution of a pericardial cyst. Ann Thorac Cardiovasc Surg. 2010 Aug;16(1):55-6. PubMed PMID: 20190713.

71. Flores RM, Riedel E, Donington JS, Alago W, Ihekweazu U, et al. Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population. J Thorac Oncol. 2010 Oct;5(10):1649-54. PubMed PMID: 20871264.

72. Garland L, Flores R, Tsao A. Individualizing mesothelioma treatment: small steps into a brighter future. Clin Lung Cancer. 2010 Nov 1;11(6):371-3. PubMed PMID: 21062727.

73. Kaufman AJ, Flores RM. Treatment of Pleural Mesothelioma: Pleurectomy and Decortication. Operative Techniques in Thoracic and Cardiovascular Surgery: A comparative Atlas. Winter 2010, 15(4): 294-306

74. Rai AJ, Flores RM. Association of malignant mesothelioma and asbestos related conditions with ovarian cancer: shared biomarkers and a possible etiological link?. Clin Chem Lab Med. 2011 Jan;49(1):5-7. PubMed PMID: 21158701.

75. Flores RM, Ihekweazu UN, Rizk N, Dycoco J, Bains MS, et al. Patterns of recurrence and incidence of second primary tumors after lobectomy by means of video-assisted thoracoscopic surgery (VATS) versus thoracotomy for lung cancer. J Thorac Cardiovasc Surg. 2011 Jan;141(1):59-64. PubMed PMID: 21055770.

76. Flores RM. Reply to difference in outcome in the transection of the pulmonary artery and vein. J Thorac Cardiovasc Surg. 2011 Feb;141(2):597-8. PubMed PMID: 21241869.

21

77. Sarkaria IS, DeLair D, Travis WD, Flores RM. Primary myoepithelial carcinoma of the lung: a rare entity treated with parenchymal sparing resection. J Cardiothorac Surg. 2011 Mar 8;6:27. PubMed PMID: 21385414; PubMed Central PMCID: PMC3061901.

78. Rizvi NA, Rusch V, Pao W, Chaft JE, Ladanyi M, et al. Molecular characteristics predict clinical outcomes: prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene. Clin Cancer Res. 2011 May 15;17(10):3500-6. PubMed PMID: 21558399; NIHMSID: NIHMS324704; PubMed Central PMCID: PMC3261615.

79. Kaufman AJ, Flores RM. Surgical treatment of malignant pleural mesothelioma. Curr Treat Options Oncol. 2011 Jun;12(2):201-16. PubMed PMID: 21465419.

80. Sarkaria IS, Bains MS, Sood S, Sima CS, Reuter VE, et al. Resection of primary mediastinal non-seminomatous germ cell tumors: a 28-year experience at memorial sloan-kettering cancer center. J Thorac Oncol. 2011 Jul;6(7):1236-41. PubMed PMID: 21610519.

81. Flores RM, Ihekweazu U, Dycoco J, Rizk NP, Rusch VW, et al. Video-assisted thoracoscopic surgery (VATS) lobectomy: catastrophic intraoperative complications. J Thorac Cardiovasc Surg. 2011 Dec;142(6):1412-7. PubMed PMID: 22014713.

82. Rosenzweig KE, Zauderer MG, Laser B, Krug LM, Yorke E, et al. Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1278-83. PubMed PMID: 22607910; NIHMSID: NIHMS460218; PubMed Central PMCID: PMC4359620.

83. Amar D, Zhang H, Shi W, Downey RJ, Bains MS, et al. Brain natriuretic peptide and risk of atrial fibrillation after thoracic surgery. J Thorac Cardiovasc Surg. 2012 Nov;144(5):1249-53. PubMed PMID: 22841166.

84. Thekkek N, Pierce MC, Lee MH, Polydorides AD, Flores RM, et al. Modular video endoscopy for in vivo cross-polarized and vital-dye fluorescence imaging of Barrett's-associated neoplasia. J Biomed Opt. 2013 Feb;18(2):26007. PubMed PMID: 23370452; PubMed Central PMCID: PMC3561596.

85. Rusch V, Baldini EH, Bueno R, De Perrot M, Flores R, et al. The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. J Thorac Cardiovasc Surg. 2013 Apr;145(4):909-910. PubMed PMID: 23415687.

86. Lim JY, Wolf AS, Flores RM. The use of surgery in mesothelioma. Lancet Respir Med. 2013 May;1(3):184-6. PubMed PMID: 24429116.

87. Watzka SB, Posch F, Pass HI, Flores RM, Hannigan GE, et al. Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure. Eur J

22

Cardiothorac Surg. 2013 May;43(5):940-5. PubMed PMID: 23045294; PubMed Central PMCID: PMC3619946.

88. Amin W, Parwani AV, Melamed J, Flores R, Pennathur A, et al. National Mesothelioma Virtual Bank: A Platform for Collaborative Research and Mesothelioma Biobanking Resource to Support Translational Research. Lung Cancer Int. 2013;2013:765748. PubMed PMID: 26316942; PubMed Central PMCID: PMC4437393.

89. Taioli E, Lee DS, Lesser M, Flores R. Long-term survival in video-assisted thoracoscopic lobectomy vs open lobectomy in lung-cancer patients: a meta-analysis. Eur J Cardiothorac Surg. 2013 Oct;44(4):591-7. PubMed PMID: 23413015.

90. Shapiro M, Kadakia S, Lim J, Breglio A, Wisnivesky JP, et al. Lobe-specific mediastinal nodal dissection is sufficient during lobectomy by video-assisted thoracic surgery or thoracotomy for early-stage lung cancer. Chest. 2013 Nov;144(5):1615-1621. PubMed PMID: 23828253.

91. Kent M, Wang T, Whyte R, Curran T, Flores R, et al. Open, video-assisted thoracic surgery, and robotic lobectomy: review of a national database. Ann Thorac Surg. 2014 Jan;97(1):236-42; discussion 242-4. PubMed PMID: 24090577.

92. Altorki NK, Yip R, Hanaoka T, Bauer T, Aye R, et al. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. J Thorac Cardiovasc Surg. 2014 Feb;147(2):754-62; Discussion 762-4. PubMed PMID: 24280722.

93. Flores R, Bauer T, Aye R, Andaz S, Kohman L, et al. Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer. J Thorac Cardiovasc Surg. 2014 May;147(5):1619-26. PubMed PMID: 24332102.

94. Posch F, Setinek U, Flores RM, Bernhard D, Hannigan GE, et al. Serum integrin-linked kinase (sILK) concentration and survival in non-small cell lung cancer: a pilot study. Clin Transl Oncol. 2014 May;16(5):455-62. PubMed PMID: 23979911.

95. Flores RM. Invited commentary. Ann Thorac Surg. 2014 Jun;97(6):1865-6. PubMed PMID: 24882279.

96. Marshall MB, Swanson SJ, Flores RM, Bauer TL. Solitary pulmonary nodules. Semin Thorac Cardiovasc Surg. 2014 Summer;26(2):157-71. PubMed PMID: 25441006.

97. Dembitzer FR, Flores RM, Parides MK, Beasley MB. Impact of histologic subtyping on outcome in lobar vs sublobar resections for lung cancer: a pilot study. Chest. 2014 Jul;146(1):175-181. PubMed PMID: 24556743.

23

98. Taioli E, Wolf AS, Camacho-Rivera M, Flores RM. Women with malignant pleural mesothelioma have a threefold better survival rate than men. Ann Thorac Surg. 2014 Sep;98(3):1020-4. PubMed PMID: 24928677.

99. Hazzard C, Wolf AS, Beasley MB, Flores RM. Benign imitation of malignancy: avoiding resection in immunoglobulin g4-related lung disease. Ann Thorac Surg. 2014 Oct;98(4):1465-7. PubMed PMID: 25282217.

100. Flores RM. Advanced lung cancer: radical surgical therapy. Thorac Surg Clin. 2014 Nov;24(4):xiii. PubMed PMID: 25441144.

101. Wolf AS, Flores RM. Extrapleural pneumonectomy for pleural malignancies. Thorac Surg Clin. 2014 Nov;24(4):471-5. PubMed PMID: 25441141.

102. Lee DS, Flores RM. Superior vena caval resection in lung cancer. Thorac Surg Clin. 2014 Nov;24(4):441-7. PubMed PMID: 25441137.

103. Xu DM, Yip R, Smith JP, Yankelevitz DF, Henschke CI. Retrospective review of lung cancers diagnosed in annual rounds of CT screening. AJR Am J Roentgenol. 2014 Nov;203(5):965-72. PubMed PMID: 25247825.

104. Black B, Szeinuk J, Whitehouse AC, Levin SM, Henschke CI, et al. Rapid progression of pleural disease due to exposure to Libby amphibole: "Not your grandfather's asbestos related disease". Am J Ind Med. 2014 Nov;57(11):1197-206. PubMed PMID: 24898907.

105. Lakha S, Gomez JE, Flores RM, Wisnivesky JP. Prognostic significance of visceral pleural involvement in early-stage lung cancer. Chest. 2014 Dec;146(6):1619-1626. PubMed PMID: 25032521.

106. Flores RM. Lung cancer survivors need lung cancer screening. J Thorac Cardiovasc Surg. 2015 Jan;149(1):53-4. PubMed PMID: 25451497.

107. Noonan CW, Conway K, Landguth EL, McNew T, Linker L, et al. Multiple pathway asbestos exposure assessment for a Superfund community. J Expo Sci Environ Epidemiol. 2015 Jan;25(1):18-25. PubMed PMID: 24756101.

108. Flores RM. Does video-assisted thoracoscopic surgical (VATS) lobectomy really result in fewer complications than thoracotomy? The biases are clear, the role of video-assisted thoracoscopic surgery less so. J Thorac Cardiovasc Surg. 2015 Feb;149(2):645. PubMed PMID: 25726888.

109. Taioli E, Wolf AS, Flores RM. Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma. Ann Thorac Surg. 2015 Feb;99(2):472-80. PubMed PMID: 25534527.

24

110. Henschke CI, Yip R, Boffetta P, Markowitz S, Miller A, et al. CT screening for lung cancer: Importance of emphysema for never smokers and smokers. Lung Cancer. 2015 Apr;88(1):42-7. PubMed PMID: 25698134.

111. Taioli E, Wolf AS, Moline JM, Camacho-Rivera M, Flores RM. Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma. Dis Markers. 2015;2015:282145. PubMed PMID: 26063951; PubMed Central PMCID: PMC4430630.

112. Yip R, Henschke CI, Yankelevitz DF, Boffetta P, Smith JP. The impact of the regimen of screening on lung cancer cure: a comparison of I-ELCAP and NLST. Eur J Cancer Prev. 2015 May;24(3):201-8. PubMed PMID: 25089376.

113. Flores RM. The mesothelioma enigma. J Thorac Cardiovasc Surg. 2015 Jun;149(6):1548-9. PubMed PMID: 25816958.

114. Wolf A, Flores RM. Multimodality therapy for malignant pleural mesothelioma: surgery plus chemoradiotherapy. In: Lung Cancer Management. Aug 2015 Volume 4(4):189-198.

115. Flores RM, Taioli E, Wolf AS. Reply: To PMID 25534527. Ann Thorac Surg. 2015 Sep;100(3):1133-4. PubMed PMID: 26354656.

116. Taioli E, Wolf AS, Flores RM. Reply: To PMID 25534527. Ann Thorac Surg. 2015 Oct;100(4):1509. PubMed PMID: 26434469.

117. Wolf, A, Rosenzweig K, Flores RM. Radiation therapy for malignant pleural mesothelioma. Special focus issue: Novel Insights Into the Pathophysiology and Treatment of Malignant Pleural Mesothelioma. In: Lung Cancer Management. Oct 2015 Volume 4(5): 243-247.

118. Yankelevitz DF, Yip R, Smith JP, Liang M, Liu Y, et al. CT Screening for Lung Cancer: Nonsolid Nodules in Baseline and Annual Repeat Rounds. Radiology. 2015 Nov;277(2):555-64. PubMed PMID: 26101879; PubMed Central PMCID: PMC4627436.

119. Taioli E, Wolf AS, Flores RM. Reply: To PMID 7436618. Ann Thorac Surg. 2015 Dec;100(6):2412. PubMed PMID: 26652550.

120. Taioli E, Wolf AS, Camacho-Rivera M, Kaufman A, Lee DS, et al. Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients. PLoS One. 2015;10(12):e0145039. PubMed PMID: 26660351; PubMed Central PMCID: PMC4682765.

121. Colon MJ, Sanjeevi S, Flores R, Reddy R. Transection of the Right Gastroepiploic Artery Does Not Exclude a Gastric Conduit in Ivor-Lewis Esophagectomy. Ann Thorac Surg. 2016 Jan;101(1):333-4. PubMed PMID: 26694268.

25

122. Hiensch RJ, Meinhof KT, Beasley MB, Reddy R, Flores RM, et al. Not your average filling defect. Neth J Med. 2016 Jan;74(1):47-8. PubMed PMID: 26819363.

123. Flores RM. The mesothelioma surgery shift. J Thorac Cardiovasc Surg. 2016 Feb;151(2):485-6. PubMed PMID: 26621318.

124. Flores RM. Pleurectomy decortication for mesothelioma: The procedure of choice when possible. J Thorac Cardiovasc Surg. 2016 Feb;151(2):310-2. PubMed PMID: 26611749.

125. Alam NZ, Flores RM. Extended video-assisted thoracic surgery (VATS) lobectomy. Minerva Chir. 2016 Feb;71(1):67-71. PubMed PMID: 26606691.

126. Taioli E, Yip R, Olkin I, Wolf A, Nicastri D, et al. Survival after Sublobar Resection for Early-Stage Lung Cancer: Methodological Obstacles in Comparing the Efficacy to Lobectomy. J Thorac Oncol. 2016 Mar;11(3):400-6. PubMed PMID: 26749486.

127. Taioli E, Lee DS, Kaufman A, Wolf A, Rosenzweig K, et al. Second Primary Lung Cancers Demonstrate Better Survival with Surgery than Radiation. Semin Thorac Cardiovasc Surg. 2016 Spring;28(1):195-200. PubMed PMID: 27568161.

128. Al-Ayoubi AM, Flores RM. Management of CT screen-detected lung nodule: the thoracic surgeon perspective. Ann Transl Med. 2016 Apr;4(8):156. PubMed PMID: 27195274; PubMed Central PMCID: PMC4860487.

129. Taioli E, Wolf AS, Camacho-Rivera M, Kaufman A, Lee DS, et al. Racial disparities in esophageal cancer survival after surgery. J Surg Oncol. 2016 May;113(6):659-64. PubMed PMID: 26865174.

130. Beasley MB, Dembitzer FR, Flores RM. Surgical pathology of early stage non-small cell lung carcinoma. Ann Transl Med. 2016 Jun;4(12):238. PubMed PMID: 27429964; PubMed Central PMCID: PMC4930521.

131. Al-Ayoubi AM, Flores RM. Lung cancer screening: did we really need a randomized controlled trial?. Eur J Cardiothorac Surg. 2016 Jul;50(1):29-33. PubMed PMID: 27005972.

132. Kaufman AJ, Palatt J, Sivak M, Raimondi P, Lee DS, et al. Thymectomy for Myasthenia Gravis: Complete Stable Remission and Associated Prognostic Factors in Over 1000 Cases. Semin Thorac Cardiovasc Surg. 2016 Summer;28(2):561-568. PubMed PMID: 28043477.

133. Yip R, Wolf A, Tam K, Taioli E, Olkin I, et al. Outcomes of lung cancers manifesting as nonsolid nodules. Lung Cancer. 2016 Jul;97:35-42. PubMed PMID: 27237025.

134. Hanson R, Evilia C, Gilmer J, Woods L, Black B, et al. Libby amphibole-induced mesothelial cell autoantibodies bind to surface plasminogen and alter collagen matrix

26

remodeling. Physiol Rep. 2016 Aug;4(15)PubMed PMID: 27519611; PubMed Central PMCID: PMC4985547.

135. Wolf AS, Flores RM. Current Treatment of Mesothelioma: Extrapleural Pneumonectomy Versus Pleurectomy/Decortication. Thorac Surg Clin. 2016 Aug;26(3):359-75. PubMed PMID: 27427530.

136. Hazzard C, Itagaki S, Lajam F, Flores RM. Anomalous Feeding of the Left Upper Lobe. Ann Thorac Surg. 2016 Sep;102(3):e193-e194. PubMed PMID: 27549539.

137. Flores RM, Liu B, Taioli E. Association of serum cotinine levels and lung cancer mortality in non-smokers. Carcinogenesis. 2016 Sep 7;PubMed PMID: 27604903.

138. Flores RM. The search for a long-lasting circumferential tracheal conduit: Belsey's problem and ours. J Thorac Cardiovasc Surg. 2016 Nov;152(5):1233-1234. PubMed PMID: 27751236.

139. Al-Ayoubi AM, Flores RM. Surgery for lung cancer invading the mediastinum. J Thorac Dis. 2016 Nov;8(Suppl 11):S889-S894. PubMed PMID: 27942411; PubMed Central PMCID: PMC5124591.

140. Kaufman AJ, Flores RM. Minimally invasive thymectomy for thymoma: does surgical approach matter or is it a question of stage?. J Thorac Dis. 2016 Dec;8(12):E1711-E1714. PubMed PMID: 28149621; PubMed Central PMCID: PMC5227222.

141. Taioli E, Paschal PK, Liu B, Kaufman AJ, Flores RM. Comparison of Conservative Treatment and Thymectomy on Myasthenia Gravis Outcome. Ann Thorac Surg. 2016 Dec;102(6):1805-1813. PubMed PMID: 28148454.

142. Henschke CI, Yip R, Smith JP, Wolf AS, Flores RM, et al. CT Screening for Lung Cancer: Part-Solid Nodules in Baseline and Annual Repeat Rounds. AJR Am J Roentgenol. 2016 Dec;207(6):1176-1184. PubMed PMID: 27726410.

143. Gilmer J, Harding T, Woods L, Black B, Flores R, et al. Mesothelial cell autoantibodies upregulate transcription factors associated with fibrosis. Inhal Toxicol. 2017 Jan;29(1):10-17. PubMed PMID: 28183202; NIHMSID: NIHMS883680; PubMed Central PMCID: PMC5554606.

144. Szeinuk J, Noonan CW, Henschke CI, Pfau J, Black B, et al. Pulmonary abnormalities as a result of exposure to Libby amphibole during childhood and adolescence-The Pre-Adult Latency Study (PALS). Am J Ind Med. 2017 Jan;60(1):20-34. PubMed PMID: 27859510.

145. Schwartz RM, Yip R, Flores RM, Olkin I, Taioli E, et al. The impact of resection method and patient factors on quality of life among stage IA non-small cell lung cancer surgical

27

patients. J Surg Oncol. 2017 Feb;115(2):173-180. PubMed PMID: 27790715; NIHMSID: NIHMS969138; PubMed Central PMCID: PMC5996390.

146. Taioli E, Flores R. Appropriateness of Surgical Approach in Black Patients with Lung Cancer-15 Years Later, Little Has Changed. J Thorac Oncol. 2017 Mar;12(3):573-577. PubMed PMID: 27544057.

147. Tantraworasin A, Saeteng S, Siwachat S, Jiarawasupornchai T, Lertprasertsuke N, et al. Impact of lymph node management on resectable non-small cell lung cancer patients. J Thorac Dis. 2017 Mar;9(3):666-674. PubMed PMID: 28449474; PubMed Central PMCID: PMC5394018.

148. Lieberman-Cribbin W, Liu B, Leoncini E, Flores R, Taioli E. Temporal trends in centralization and racial disparities in utilization of high-volume hospitals for lung cancer surgery. Medicine (Baltimore). 2017 Apr;96(16):e6573. PubMed PMID: 28422849; PubMed Central PMCID: PMC5406065.

149. Flores RM, Nicastri D, Bauer T, Aye R, Andaz S, et al. Computed Tomography Screening for Lung Cancer: Mediastinal Lymph Node Resection in Stage IA Nonsmall Cell Lung Cancer Manifesting as Subsolid and Solid Nodules. Ann Surg. 2017 May;265(5):1025-1033. PubMed PMID: 27232256; NIHMSID: NIHMS969139; PubMed Central PMCID: PMC5995117.

150. Lavin Y, Kobayashi S, Leader A, Amir ED, Elefant N, et al. Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses. Cell. 2017 May 4;169(4):750-765.e17. PubMed PMID: 28475900; NIHMSID: NIHMS873618; PubMed Central PMCID: PMC5737939.

151. Barta JA, Henschke CI, Flores RM, Yip R, Yankelevitz DF, et al. Lung Cancer Diagnosis by Fine Needle Aspiration Is Associated With Reduction in Resection of Nonmalignant Lung Nodules. Ann Thorac Surg. 2017 Jun;103(6):1795-1801. PubMed PMID: 28274517.

152. Kaufman AJ, Kahn ET, Villena-Vargas J, Steele JG, Flores RM. Laparoscopic Repair of an Intrapericardial Diaphragmatic Hernia After Convergent Maze Procedure. Ann Thorac Surg. 2017 Jun;103(6):e541-e543. PubMed PMID: 28163037.

153. Schwartz RM, Watson A, Wolf A, Flores R, Taioli E. The impact of surgical approach on quality of life for pleural malignant mesothelioma. Ann Transl Med. 2017 Jun;5(11):230. PubMed PMID: 28706898; PubMed Central PMCID: PMC5497110.

154. Wolf AS, Flores RM. Special issue: mesothelioma. Ann Transl Med. 2017 Jun;5(11):229. PubMed PMID: 28706897; PubMed Central PMCID: PMC5497116.

28

155. Shayani J, Flores RM, Hakami A. Mediastinal lymph node dissection: the debate is not resolved. J Thorac Dis. 2017 Jul;9(7):1848-1850. PubMed PMID: 28839981; PubMed Central PMCID: PMC5542963.

156. Rehmani SS, Al-Ayoubi AM, Ayub A, Barsky M, Lewis E, et al. Three-Dimensional-Printed Bioengineered Tracheal Grafts: Preclinical Results and Potential for Human Use. Ann Thorac Surg. 2017 Sep;104(3):998-1004. PubMed PMID: 28610885.

157. Taioli E, Liu B, Nicastri DG, Lieberman-Cribbin W, Leoncini E, et al. Personal and hospital factors associated with limited surgical resection for lung cancer, in-hospital mortality and complications in New York State. J Surg Oncol. 2017 Sep;116(4):471-481. PubMed PMID: 28570755.

158. Taioli E, Schwartz RM, Lieberman-Cribbin W, Moskowitz G, van Gerwen M, et al. Quality of Life after Open or Minimally Invasive Esophagectomy in Patients With Esophageal Cancer-A Systematic Review. Semin Thorac Cardiovasc Surg. 2017 Autumn;29(3):377-390. PubMed PMID: 28939239.

159. Ayub A, Rehmani SS, Al-Ayoubi AM, Raad W, Flores RM, et al. Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study. Ann Thorac Surg. 2017 Oct;104(4):1131-1137. PubMed PMID: 28709663.

160. Wolf AS, Swanson SJ, Yip R, Liu B, Tarras ES, et al. The Impact of Margins on Outcomes After Wedge Resection for Stage I Non-Small Cell Lung Cancer. Ann Thorac Surg. 2017 Oct;104(4):1171-1178. PubMed PMID: 28669499.

161. Lieberman-Cribbin W, Galsky M, Casey M, Liu B, Oh W, et al. Hospital Centralization Impacts High-Risk Lung and Bladder Cancer Surgical Patients. Cancer Invest. 2017 Nov 26;35(10):652-661. PubMed PMID: 29243986.

162. Taioli E, van Gerwen M, Mihalopoulos M, Moskowitz G, Liu B, et al. Review of malignant pleural mesothelioma survival after talc pleurodesis or surgery. J Thorac Dis. 2017 Dec;9(12):5423-5433. PubMed PMID: 29312753; PubMed Central PMCID: PMC5756994.

163. Liu B, Flores RM, Taioli E. Patterns of elective lobectomy for lung cancer. J Surg Res. 2017 Dec;220:59-67. PubMed PMID: 29180212.

164. Lee DS, Flores RM. Management of NSCLC invading the superior vena cava. Operative Techniques in Thoracic and Cardiovascular Surgery. Winter 2017 Volume 22(4):224-234.

165. Schwartz RM, Gorbenko K, Kerath SM, Flores R, Ross S, et al. Thoracic surgeon and patient focus groups on decision-making in early-stage lung cancer surgery. Future Oncol. 2018 Jan;14(2):151-163. PubMed PMID: 29231095; PubMed Central PMCID: PMC5992563.

29

166. Flores RM. Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery. J Thorac Cardiovasc Surg. 2018 Jan;155(1):403-404. PubMed PMID: 28918206.

167. Rehmani S, Bhora F, Flores R. Robotic Lung Cancer Surgery: A Missed Opportunity and a Faulty Conclusion. Ann Surg. 2018 Feb;267(2):e34. PubMed PMID: 27643927.

168. Miller A, Szeinuk J, Noonan CW, Henschke CI, Pfau J, et al. Libby Amphibole Disease: Pulmonary Function and CT Abnormalities in Vermiculite Miners. J Occup Environ Med. 2018 Feb;60(2):167-173. PubMed PMID: 29200190; NIHMSID: NIHMS907538; PubMed Central PMCID: PMC5805586.

169. Nicastri DG, Flores RM. Chylothorax: Abdominal approach. J Thorac Cardiovasc Surg. 2018 Feb;155(2):814. PubMed PMID: 29106894.

170. Wolf A, Liu B, Leoncini E, Nicastri D, Lee DS, et al. Outcomes for Thoracoscopy Versus Thoracotomy Not Just Technique Dependent: A Study of 9,787 Patients. Ann Thorac Surg. 2018 Mar;105(3):886-891. PubMed PMID: 29397101.

171. Tantraworasin A, Taioli E, Liu B, Kaufman AJ, Flores RM. Underperformance of Mediastinal Lymph Node Evaluation in Resectable Non-Small Cell Lung Cancer. Ann Thorac Surg. 2018 Mar;105(3):943-949. PubMed PMID: 29397099.

172. Henschke CI, Salvatore M, Cham M, Powell CA, DiFabrizio L, et al. Baseline and annual repeat rounds of screening: implications for optimal regimens of screening. Eur Radiol. 2018 Mar;28(3):1085-1094. PubMed PMID: 28983713.

173. Wolf AS, Flores RM. Mesothelioma: Live to fight another day. J Thorac Cardiovasc Surg. 2018 Apr;155(4):1855-1856. PubMed PMID: 29338864.

174. Tuminello S, Liu B, Wolf A, Alpert N, Taioli E, et al. Comparison of In-Hospital and Long-term Outcomes of Sublobar Lung Cancer Surgery by VATS and Open Techniques. Am J Clin Oncol. 2018 Apr 10;PubMed PMID: 29642076.

175. Tantraworasin A, Taioli E, Liu B, Flores RM, Kaufman AJ. The influence of insurance type on stage at presentation, treatment, and survival between Asian American and non-Hispanic White lung cancer patients. Cancer Med. 2018 May;7(5):1612-1629. PubMed PMID: 29575647; PubMed Central PMCID: PMC5943464.

176. Tuminello S, Wolf A, Taioli E, Flores R. Comparison of Wedge vs Lobar Resection for Stage 1 NSCLC Patients: A SEER-Medicare Analysis. Ann Thorac Surg. 2018 May 12;PubMed PMID: 29763595.

177. Nicastri DG, Alpert N, Liu B, Wolf A, Taioli E, et al. Oxygen Use After Lung Cancer Surgery. Ann Thorac Surg. 2018 Jun 18;PubMed PMID: 29928852.

30

178. Diegel R, Black B, Pfau JC, McNew T, Noonan C, et al. Case series: rheumatological manifestations attributed to exposure to Libby Asbestiform Amphiboles. J Toxicol Environ Health A. 2018;81(15):734-747. PubMed PMID: 29927712.

179. Flores R, Taioli E, Yankelevitz DF, Becker BJ, Jirapatnakul A, et al. Initiative for Early Lung Cancer Research on Treatment: Development of Study Design and Pilot Implementation. J Thorac Oncol. 2018 Jul;13(7):946-957. PubMed PMID: 29578108.

180. Henschke CI, Salvatore M, Cham M, Powell CA, DiFabrizio L, et al. Correction to: Baseline and annual repeat rounds of screening: implications for optimal regimens of screening. Eur Radiol. 2018 Jul;28(7):3114. PubMed PMID: 29442132.

181. Rehmani SS, Liu B, Al-Ayoubi AM, Raad W, Flores RM, et al. Racial Disparity in Utilization of High-Volume Hospitals for Surgical Treatment of Esophageal Cancer. Ann Thorac Surg. 2018 Aug;106(2):346-353. PubMed PMID: 29684373.

182. Flores RM, Yankelevitz DF. Lung Cancer Screening: The True Benefit. Ann Thorac Surg. 2018 Aug;106(2):319-320. PubMed PMID: 29654725.

183. Tuminello S, Schwartz RM, Liu B, Mhango G, Wisnivesky J, Flores R, Taioli E. Opioid Use After Open Resection or Video-Assisted Thoracoscopic Surgery for Early-Stage Lung Cancer. JAMA Oncology 2018 Sept: PubMed PMID: 30264153. Online: 10.1001/jamaoncol.2018.4387.

31

Book Chapters, Reviews, Monographs 1. Jaklitsch, MT, Flores RM, DeCamp MM Jr. Thoracoscopy and video-assisted thoracic

surgery. In: Brooks DC (ed.) Minimally Invasive Surgery 1998. Springer-Verlag 145-157. ISBN 0387983384/9780387983387.

2. Flores RM, Norberto JJ, Jaklitsch MT, Sugarbaker DJ. Non-small cell lung cancer surgical staging. In: Skarin A (ed.) Multimodality Treatment of Lung Cancer. Lung Biology in Health and Disease 2000, Taylor & Francis Group, New York. ISBN 0824702360/ 9780824702366.

3. DeCamp MM Jr, Flores RM. Non-small cell lung cancer: Surgery for Stage I and II Disease. In: Skarin A (ed.). Multimodality Treatment of Lung Cancer. Volume 140 Lung Biology in Health and Disease 2000. Taylor & Francis Group, New York. ISBN 0824702360/ 9780824702366.

4. Dominguez Parra LM, Ruiz GC, Rincon DG, Gamboa Vignole CF, Flores RM, Schnneweiss LG. Neoplasias del torax cancer de pulmon. In: Manual de Oncologia: Procedimientos medicoquirurgicos. Segunda edicion. McGraw-Hill Interamericana. Mexico, 2003.

5. Dominguez Parra LM, Flores RM, Schnneweiss LG. Neoplasias del torax mesotelioma. In: Manual de Oncologia: Procedimientos medicoquirurgicos. Segunda edicion. McGraw-Hill Interamericana. Mexico, 2003.

6. Flores RM, Rusch VW. Thoracoscopy and video-assisted thoracic surgery. In: Whilmore DW, Brennan MF, Harken AH, Holcroft JW, Meakins JL,(eds). Care of the Surgical Patient (ACS Surgery). New York: Scientific American Medicine, 2003 WebMD.

7. Flores RM. Surgical Management of Primary Mediastinal Germ Cell Tumors. CTSNET Experts' Techniques at www.ctsnet.org 2004.

8. Flores RM. VATS Lobectomy for Early Stage Lung Cancer. CTSNET Experts' Techniques at www.ctsnet.org 2004.

9. Flores RM, Rusch VW. Diffuse malignant mesothelioma. In: Shields TW, LoCicero J, Ponn RB, Rusch VW (eds). General Thoracic Surgery, Sixth Edition. Lippincott, Williams & Wilkins, Philadelphia, 2005.

10. Flores RM, Park R, Rusch VW. Video-assisted thoracic surgery. 4 Alimentary Tract and Abdomen. ACS Surgery Online. Souba WW, Fink MP, Jurkovich GJ et al., (eds.)WebMD Inc., New York 2004. http://www.acssurgery/. March 2005.

11. Flores RM, Rusch VW. Staging of mesothelioma. In: Pass HI, Vogelzang NJ, Carbone M, (eds.) Malignant Mesothelioma. Springer-Verlag, New York, 2005. ISBN 978-0-387-22949-2

32

12. Flores RM, Rosenzweig KE, Rusch VW. Surgery and postoperative radiotherapy. In: Pass HI, Vogelzang NJ, Carbone M, (eds.) Malignant Mesothelioma. Springer-Verlag, New York, 2005. ISBN 978-0-387-22949-2.

13. Flores RM. Management of benign variants of mesothelioma. In: Pass HI, Vogelzang NJ, Carbone M (eds.). Springer-Verlag, New York. 2005. ISBN 978-0-387-22949-2.

14. Zhao B, Schwartz LH, Flores R, Liu F, Kijewski P, Krug L, Rusch V. Assessment of therapy response to mesothelioma by measuring tumor volume on CT scan. Image Processing, Proc. SPIE 2005 Medical Imaging; 5747:866-871.

15. Flores RM, Park R, Rusch VW. Video-assisted thoracic surgery. In: Souba WW, Fink MP, Jurkovich GJ et al., (eds.) 4 Alimentary Tract and Abdomen. ACS Surgery Online. WebMD Inc., New York, 2006.

16. Flores RM, Alam NZ. Video-assisted thoracic surgery major lung resections. In: Ferguson M, (ed.) Difficult Decisions in Thoracic Surgery: An Evidence-Based Approach, Second Edition. Springer, London, 2007. ISBN 978-1-84628-384-0.

17. Eiten R, Flores R, Chi D. Video assisted thorascopy. In: Kupets R, Covens A, ed. Laparoscopic Surgery for Gynecologic Oncology. McGraw-Hill New York 2008 ISBN 0071493247 / 9780071493246.

18. Kehoe SM, Flores RM. Chest tube placement and video-assisted thoracoscopic surgery. In: Levine DA, Barakat RR, Abu-Rustum NR, (eds.) In: Atlas of Procedures in Gynecologic Oncology, Second Edition. Informa Healthcare, UK 2008:257-265. ISBN 978-1841844985.

19. Flores R, Alam N. Management of mediastinal tumors not of thymic origin. In: Pass HI, Carbone DP, Johnson DH, Minna JD, Scagliotti GV, Turrisi AT, (eds). Principles and Practices of Lung Cancer: The Official Reference Text of the International Association of the Study of Lung Cancer (IASLC) Fourth Edition. Lippincott Williams & Wilkens, Philidephia 2012:961-970. ISBN 978-078177365-2.

20. Park BJ, Flores RM, Rusch VW. Robotic video-assisted thoracicsurgery lobectomy. In: Patterson, Pearson, Cooper, Deslauriers, Rice, Luketich, Lerut(eds). Pearson’s Thoracic & Esophageal Surgery, Third Edition. Churchill Livingstone: Elsevier, 2008:989-998. ISBN 978-0443068614.

21. Routledge T, Flores R. US trials in mesothlioma. In: Baldi A. (ed.) Mesothelioma from Bench Side to Clinic. New York: Nova Publishers, 2008: 521-536. ISBN 1-60021-789-3.

22. Alam N, Flores RM, Rusch VW. Pleurectomy and decortication for malignant pleural diseases. In: Sugarbaker DJ, Bueno R, Krasna MJ, Mentzer SJ, Zellos L. (eds.) Adult Chest Surgery: Concepts and Procedures. McGraw Hill, New York 2009: 860-867 ISBN 0071434143 / 9780071434140.

33

23. Alam N, Flores R. Malignant pleural mesothelioma: Patient selection for pleurectomy. In:

Ferguson M, (ed.) Difficult Decisions in Thoracic Surgery: An Evidence-Based Approach, Second Edition. Springer-Verlag, London, 2011. ISBN 978-1-84996-364-0

24. Flores R, Alam N. Surgery for pleural disease in the elderly. In: Katlic M, (ed.) Cardiothoracic Surgery in the Elderly. Springer-Verlag, London, 2011. ISBN 978-1-4419-0891-9.

25. Park BJ, Flores R. Chest Wall Tumors In: Shields TW, Locicero J, Reed CE, Feins RH (eds.) Shield’s General Thoracic Surgery 7th Edition. Wolters Kluwer Health, Philadelphia, PA. 2011. ISBN 978-078177982-1.

26. Andrade R, Flores R. Resecciones pulmonares mediante cirugia videotorascopica. In: Metodos de Exploracion y Diagnostico.

27. Alam, N, Flores RM. Surgical management of empyema (Chapter 31). In: Kaiser, L. Kron, I, Spray T (eds.) Mastery of Cardiothoracic Surgery, 3rd Edition. Lippincott Williams & Wilkins Philadelphia 2013. ISBN 9781451113150.

28. Lim J, Flores R. Three incision esophagectomy. In: Cohen-Kligerman B, Yang, S, Sirgedas L (eds). Current Therapy in Thoracic and Cardiovascular Surgery. Elsevier, St. Louis 2012 (submitted).

29. Finley D, Flores R. Pleural effusions and empyema thoracis (Section 6). In: Bope ET, Kellerman R (eds). Conn’s Current Therapy 2013. Elsevier, St. Louis 2012. ISBN 978-1-4557-0295-4.

30. Flores R. Pleurectomy and decortication for mesothelioma (Chapter 40). In: Dienemann H, Detterbeck F (eds). Chest Surgery Atlas 2013. Springer, Philadelphia PA, 2015. ISBN 978-3642120435.

31. Hazzard C, Kaufman A, Flores R. Mediastinal tumors (Chapter 54). In: Whippen D. The IASLC Multidisciplinary Approach to Thoracic Oncology. International Association for the Study of Lung Cancer, Colorado 2013. ISBN 978-1940488028.

32. Alam, N, Flores RM. Malignant mesothelioma – clinical and imaging findings. In: Antitila S, Boffetta P, Kurt S (eds.) Occupational Cancer: Clinical and Pathological Features. Springer-Verlag, London, England, 2014. ISBN 978-1-4471-2824-3

33. Alam N, Flores RM. Pleurectomy and decortication for malignant pleural diseases. In: Sugarbaker DJ, Bueno R, Colson YL, Jaklitsch MT, Krasna MJ, Mentzer SJ, (eds.) Adult Chest Surgery: Concepts and Procedures Second Edition. McGraw Hill, New York 2015: 990-997 ISBN 9780071781893/0071781897.

34

34. Lee, DS, Flores RM. Surgery for mesothelioma. In: Guitron J, (ed). Thoracic Oncology: A Multidisciplinary Approach. John Wiley & Sons, Inc. Hoboken 2015. ISBN 978-1118575314

35. Flores RM. Preface. In: Flores RM (editor). Thoracic Surgery Clinics 24 (Vol 24, Issue

4). Advanced Lung Cancer: Radical Surgical Therapy. Elsevier, New York 2015. ISBN 9780323323895

36. Wolf A, Flores RM. Surgery approaches in mesothelioma (Chapter 13). In: Testa JR (ed.) Asbestos and Mesothelioma. Springer, Switzerland 2017. ISBN 978-3-319-53560-9.

37. James L, Wolf A, Flores R. Broncho-pulmonary and Thymic Carcinoids, Other Endocrine

Tumors. In: Pertsemlidis D, Inabnet WB, Gagner M (eds.) K24192 Endocrine Surgery, Second Edition. Informa - CRC Press, UK. 2017. ISBN 9781482259599.

38. Wolf A, Flores RM. Role of extrapleural pneumonectomy in MPM. In: Mineo TC (ed.). Malignant Pleural Mesothelioma: Present Status and Future Directions. Bentham, United Arab Emirates, 2015. ISBN 978-1-68108-194-6

39. Lee DS, Flores RM. Chest wall tumors. In: (digital program) Lillemoe, de Moya, House and Hutter (eds.) Clinical Decision Support: Surgery. Decision Support In Medicine, LLC, Wilmington, DE

40. Wolf A, Gomez J, Flores RM. Chemotherapy. In: Malignant Pleural Mesothelioma. Future Medicine, London, 2015. In press.

41. Wolf A, Flores R. Current Treatment of Mesothelioma: EPP vs pleurectomy. In: Thoracic Surgery Clinics: Current Controversies in Thoracic Surgery (Vol 26, Issue 3). Elsevier, 2016. ISBN 978-0323459914

42. Hazzard C, Kaufman A, Flores R. Mediastinal Tumors (Chapter 54). In: Pass H, Ball D, Scagliotti G (eds.) IASLC Thoracic Oncology Second Edition. Elsevier, 2017. ISBN 9780323523578.

43. Nicastri D, Flores R. Chest Wall Tumors (Osteogenic, Neurogenic, Vascular, & Metastatic). In: Locicero J, Feins RH, Colson YL, Rocco G (eds.) Shield’s General Thoracic Surgery 8th Edition. Wolters Kluwer Health, Philadelphia, PA. 2018. ISBN 978-1451195224.

44. Lee D, Salvatore M, Yankelevitz D, Henschke C, Flores R. Standard Radiographic Evaluation of the Lungs and Chest. Section III – Thoracic Imaging. In: LoCicero J, Feins R, Rocco G, Colson Y, Meyers B (eds.) Shield’s General Thoracic Surgery, 8th Edition. Lippincott Williams & Wilkins, Division of Wolters Kluwer Health. Philadelphia, PA. 2018. ISBN 978-1451195224.

35

Videos, Abstracts and Posters 1. Patel A, Whitehouse B, Kurland B, Flores RM, Simmons J, Boley SJ. Effects of 21- aminosteroids on mesenteric ischemia. FASEB 1993. New Orleans, LA. 2. Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, DeCamp MM Jr, Swanson SJ, Bueno R, Lukanich JM, Baldini EH, Mentzer SJ. Resection margins, extrapleural nodal status, and cell type determine survival in trimodality therapy of malignant pleural mesothelioma (MPM): Results in 183 patients. Seventy-eighth meeting of the American Association of Thoracic Surgery. 1998. Boston, MA. 3. Sugarbaker DJ, Flores RM. Instrumental and technological developments in VATS. Fifth International Symposium of Thoracoscopic Surgery. 1998. Tokyo, Japan. 4. Flores RM, Akhurst T, Rusch VW. Positron emission tomography (PET) defines metastatic disease but not locoregional disease in patients undergoing resection for malignant pleural mesothelioma (MPM). Presented at the 82nd Annual Meeting of the American Association for Thoracic Surgery. 2002. Washington, D.C. 5. Extrapleural pneumonectomy in children. Poster presentation. IPSO/APSA Meeting. Ponte Vedra, FL. May 26, 2004 6. Flores RM, Akhurst T, Gonen M, Larson SM, Rusch VW. FDG-PET predicts survival in patients with malignant pleural mesothelioma. Proc ASCO 2003;22: 620 (Abstract

2495).

7. Flores RM, Krug K, Rosenzweig E, Vincent A, Akhurst T, Heelan R, Rusch VW. Induction Chemotherapy, extrapleural pneumonectomy (EPP), and adjuvant hemithoracic radiation are feasible and effective for locally advanced malignant pleural mesothelioma (MPM). J Clin Onc. ASCO Annual Meeting Proceedings (Post- Meeting Edition), Vol 22, No 14S (July 15 Supplement), 2004:7193. 8. Flores RM, Akhurst T, Krug L, Gonen M, Dycoco J, Rosenzweig K, Larson SM, Downey RJ, Rusch VW. Decreased PET SUV after induction chemotherapy is associated with improved survival in malignant pleural mesothelioma (MPM). American Society of Clinical Oncology. 2005. Orlando, Fl. 9. Flores RM, Park B, Rusch VW. A comparison of 100 VATS versus robotic-assisted lobectomy cases for early stage lung cancer. Is the robot worth the time? International Society for Minimally Invasive Cardiothoracic Surgery. 2005. New York, N.Y. 10. Flores R, Zakowski M, Venkatramen E, Krug L, Rosenzweig K, Dycoco J, Yeoh C, Lee C, Bains M, Rusch V. Malignant Pleural Mesothelioma (MPM): new predictors of survival and an analysis of the impact of current treatment. International Association for the Study of Lung Cancer, 11th World Conference on Lung Cancer. 2005. Barcelona, Spain.

36

11. Wickersham C, Wagner K, Paolilli D, Flores RM. Extrapleural pneumonectomy for mesothelioma: Specialized nursing care is essential to minimize postoperative complications. Oncology Nursing Society. 2005. Orlando, Fl. 12. Stark R, Cahill M, Checchia T, Flores R, Cass C. Video assisted thoracoscopy for lobectomy. Association of Perioperative Registered Nurses. 2005. New Orleans, LA. 13. Flores RM. Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: The Memorial Sloan-Kettering experience. Lung Cancer 2005; July;49 Suppl 1:S71-4. 14. Flores RM. The role of PET in the surgical management of malignant pleural mesothelioma. Lung Cancer 2005; July;49 Suppl 1:S27-32. 15. Moskovitz AH, Rizk NP, Venkatraman E, Flores RM, Park BH, Bains MS, Rusch VW. Mortality increases for octogenarians undergoing esophagogastrectomy for esophageal cancer. Society of Thoracic Surgeons 42nd Annual Meeting, 1/30-2/1/06 Chicago, Ill. 16. Rosenzweig KE, Krug LM, Flores RM, Yorke E, Mageras G, Nehmeh S, Erdi Y, Stechel E, Rusch VW. Intensity modulated hemithoracic radiation therapy for malignant pleural mesothelioma (MPM) after pleurectomy/ decortication. Int J Rad Onc Biol Phys 2007;69(3S):S494-495. 17. Flores RM, Park BJ, Dycoco J, Arnova A, Hirth Y, Rizk NP, Bains M, Downey RJ, Rusch VW. VATS Lobectomy Versus Thoracotomy for Lung Cancer – Results in 741 Patients. American Association for Thoracic Surgery 88th Annual Meeting. May 10- 14, 2008 San Diego, CA. 18. Onaitis MW, Haney J, Petersen R, Saltz LB, Flores RM, Rizk N, Bains MS, D’Amico T, Kemeny NE, Rusch VW, Downey RJ. Factors influencing outcome after pulmonary resection for colorectal cancer (CRC) metastases in the current era. J Clin Oncol 2008; 26(15S):184S. 19. Rizk NP, Bains MS, Park BJ, Flores RM, Downey RJ, Goodman K, Ilson DH, Rusch VW. Use of SUVmax to predict response to neoadjuvant chemoradiotherapy in patients with adenocarcinoma of the distal esophagus and GE junction. J Clin Oncol 2008; 26(15S):229S. 20. Huang J, Rizk N, Travis W, Riely GJ, Park BJ, Bains MS, Flores RM, Downey RJ, Rusch VW. Comparison of patterns of relapse in thymic carcinoma and thymoma. J Clin Oncol 2008; 26(15S):406S.

37

21. Park BJ, Ishill NM, Flores RM, Gawiak CT, Shen R, Rizk N, Bains MS, Downey RJ, Ostroff J, Burkhalter J, Rusch VW. Prospective comparison of postoperative quality of life (QOL) in patients undergoing lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for non-small cell lung cancer (NSCLC). J Clin Oncol 2008; 26(15S):407S. 22. Diaz JP, Abu-Rustum NR, Sonoda Y, Downey RJ, Park BJ, Flores RM, Leitao MM Jr., Barakat RR, Chi DS. Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patients. 40th Annual Meeting on Women’s Cancer. Society of Gynecologic Oncologists, Feb 5-8, 2009, Henry B Gonzalez Convention Center, San Antonio, TX. 23. Ilson D, Bains M, Rizk N, Rusch V, Flores R, Park B, Shah M, Kelsen D, Miron B, Goodman K; Memorial Sloan-Kettering Cancer Center, New York, NY. Phase II trial of preoperative bevacizumab (Bev), irinotecan (I), cisplatin ©, and radiation (RT) in esophageal adenocarcinoma: preliminary safety analysis. American Society of Clinical Oncology May 29-June 2, 2009, Orlando, FL. 24. Yorke ED, Lacer B, Krug LM, Flores R, Nehmeh S, Erdi Y, Stechel E, Rusch V, Rosenzweig KE. Radiotherapy treatment planning for patients with malignant pleural mesothelioma (MPM) using 18-FDG Positron Emission Tomography (PET). International Journal of Radiation Oncology Biology Physics 2008 Supplement 72(1):S460. 25. Finley DJ. MD1, Chawla M. MD2, Stock C. MD1, Sima C. MS3, Adusumilli PS. MD1, Bains MS. MD1, Downey RJ. MD1, Flores R. MD1, Huang J. MD1, Park BJ. MD1, Rizk N, MD1, Zakowski MF. MD4 and Rusch V. MD1Memorial Sloan-Kettering Cancer Center, New York, NY The Accuracy of Intraoperative Cytologic Evaluation Durin Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Mediastinal and Hilar Lymphadenopathy. Poster at the American Thoracic Society (ATS) San Diego, CA (May 3-8, 2009). 26. Rusch V, Giroux D, Edwards J, Waller D, Kennedy C, Ruffini E, Pass H, Rice D, Flores R, de Perrot M, Crowley J, Goldstraw P. Initial analyses of the IASLC International database for malignant pleural mesothelioma. Accepted for oral abstract presentation. International Association for the Study of Lung Cancer (IASLC) 13th World conference on Lung Cancer. San Francisco, CA (August 2, 2009) Journal of Thoracic Oncology Vol 4, Iss 9, Supp 1, September 2009: S322. 27. Barnett SA, Park BJ, Plourde G, Zheng J, Bains MS, Downey RJ, Flores RM, Rizk NP, Shen R, Kris MG, Akhurst TJ, Rusch VW. PET response and long term survival after resection of non-small cell lung cancer (NSCLC) following induction therapy (IT). E-Poster: PD8.4.1 at the International Association for the Study of Lung Cancer (IASLC),

San Francisco, CA (July 31 – August 4, 2009) Journal of Thoracic Oncology Vol 4, Iss 9, Supp 1, September 2009: S526.

38

28. Zhao B., Krug L., Liu F., Guo P., Ishill NM., Moskowitz CS., Rusch VW, Flores RM, Schwarta LH. Measurement of tumor volumes in patients with malignant pleural mesothelioma (MPM) correlates with prognosis. International Association for the Study of Lung Cancer (IASLC) 13th World conference on Lung Cancer. San Francisco, CA (July 31 – August 4, 2009) Journal of Thoracic Oncology Vol 4, Iss 9, Supp 1, September 2009:S462. 29. Towe C., Huang J., Williams T., Riely GJ., Dycoco J., Rizk N., Park B., Bains M., Flores R., Downey R., Rusch V. Recent clinical experience with thymic neuroendocrine tumors. International Association for the Study of Lung Cancer (IASLC) 13th World Conference on Lung Cancer. San Francisco, CA (July 31 – August 4, 2009) Journal of Thoracic Oncology Vol 4, Iss 9, Supp 1, September 2009: S762. 30. Rosenzweig K., Krug L., Laser B., Yorke E., Flores R., Brown A., Rusch VW. Feasibility of pleural intensity-modulated radiation therapy (IMRT) for malignant pleural mesothelioma. International Association for the Study of Lung Cancer (IASLC) 13th World Conference on Lung Cancer. San Francisco, CA (July 31 – August 4, 2009) Journal of Thoracic Oncology Vol 4, Iss 9, Supp 1, September 2009: S774. 31 Flores RM, Riedel E, Donington JS, Krug L, Rosenzweig K, Adusumilli P, Crbone M, Rusch VW, Pass HI. Frequency of use and outcome of surgical resection in the management of malignant mesothelioma in a community-based population: Results in 5, 937. American Society of Clinical Oncology (ASCO) 45th Annual Meeting. Orlando, FL May29-June 2, 2009 J Clin Oncol 27:15s, 2009 (suppl; abstr 7510). 32. Abstract #337: Diaz JP, Park BJ, Nwabuobi C, Flores RM, Sonoda Y, Downey RJ, Aby- Rustum NR, Barakat RR, Chi DS. Morbidity and mortality of intrathoracic cytoreductive surgery in the management of advanced and recurrent ovarian carcinoma. Society of Gynecologic Oncologists (SGO) Moscone West Convention Center. San Francisco, CA March 14-17, 2010. 33. Flores RM, Ihekweazu UN, Rizk N, Dycoco J, Bains MS, Downey RJ, Adusumilli P, Finley DJ, Huang J, Rusch VW, Sarkaria I, Park B. Patterns of recurrence and incidence of second primary tumors after lobectomy by VATS versus Thoracotomy for Lung Cancer. American Association for Thoracic Surgery. Toronto, ON, May 1-5, 2010. 34. Wickersham C, Thom B, Flores R. Clinical relevance of postoperative EKG changes in patients undergoing an extrapleural pneumonectomy. Oncology Nursing Society Research Conference, Los Angeles, CA, February 10-12, 2011. 35. Shapiro M, Flores RM . Anomalous pulmonary vein drainage (APVD) is not a contraindication for VATS lobectomy. CHEST 2012, Atlanta, GA, October 23, 2012.

39

36. Kent MS, Wang T, Whyte R, Flores R, Gangadharan S. Open, VATS and robotic lobectomy: review of a national database. Southern Thoracic Surgical Association, Naples, FL November 8, 2012. 37. Obeso Carillo GA, Castillo J, Garcia Fontan G, Peltz G, Duran Toconas JC, Blanco Ramos M, Pena Gonzalez EI, Albort Ventura J, Canizares Carretero MA, Flores RM. Angiosarcoma pulmonary primario, una neoplasia excepcional con muy mal pronostico. IV Congreso De La Sociedad Espanola De Cirugia Toracica Madrid, Spain May 10, 2013. 38. Flores RM. Extrapleural Pneumonectomy for Mesothelioma. United States.

CTSNet October 2013. 39. Inabnet WB, Said M, Flores R, Warner R, Herman SD, Naides A, Marin ML. En bloc resection of metastatic cervical carcinoid tumor with right common carotid artery invasion. Video presentation at Annual Clinical Congress, American College of Surgeons, Washington, DC, October 7, 2014. 40. Lim JY, Flores RM, Izadmehr S, McClinch K, Kastrinsky D, Kaufman AJ, Ohlmeyer M, Narla G, Ramanathan SY. Small molecule activators of protein phosphatase 2A (PP2A) inhibit malignant pleural mesothelioma (MPM) cell growth.

40

Invited Lectures and Presentations

1. Surgical management of non-small cell lung cancer. Surgical Grand Rounds Memorial Sloan-Kettering Cancer Center, New York, New York. September 21, 2001. 2. Surgical management of malignant pleural mesothelioma. General Thoracic Surgery Club of New York. Rockefeller University, New York, New York. November 17, 2001. 3. Malignant pleural mesothelioma. Saint Mary’s Hospital, Waterbury, Connecticut. February 20, 2002. 4. Surgical management of malignant pleural mesothelioma. St. Lukes-Roosevelt Medical Center, New York, New York. March 13 2002. 5. Surgical management of non-small cell lung cancer. Mercy Hospital, Long Island, New York. April 17, 2002. 6. Malignant pleural mesothelioma: Clinical diagnosis, treatment, and management. The 18th UICC International Cancer Congress, Oslo, Norway. July 3, 2002.

7. Staging and surgical therapy of malignant pleural mesothelioma. The 7th Annual Perspectives in Thoracic Oncology. New York, New York. October 5, 2002. 8. VATS lobectomy. Surgical Grand Rounds, Memorial Sloan-Kettering Cancer Center, New York, New York. April 22, 2003. 9. VATS lobectomy. Advanced Minimally Invasive Surgery in Oncology Conference, New York, NewYork. May 9, 2003. 10. FDG-PET predicts survival in malignant pleural mesothelioma. American Society of Clinical Oncology, Chicago, Illinois. June 2, 2003. 11. VATS lobectomy. Rockefeller University. National Corporate Medical Association, New York, New York. June 12, 2003. 12. VATS lobectomy for early stage lung cancer. Multimodality therapy for bronchogenic and esophageal cancer. Ohio State University Columbus, Columbus,Ohio September 12, 2003. 13. VATS lobectomy for early stage lung cancer. Saint Mary’s Hospital, Waterbury, Connecticut. September 17, 2003. 14. Malignant pleural mesothelioma: Multimodality treatment. Columbia-Presbyterian Medical Center, New York, New York. September 25, 2003.

41

15. Malignant pleural mesothelioma: Multimodality treatment. Lenox Hill Hospital, Oncology Grand Rounds. New York, New York. October 14, 2003. 16. VATS lobectomy and mediastinal nodal dissection for early stage lung cancer . Latin American Conference on Lung Cancer. Guaruja, Brazil. March 17-21, 2004. 17. Malignant pleural mesothelioma. Latin American Conference on Lung Cancer. Guaruja, Brazil. March 17-21, 2004. 18. VII Meeting of the International Mesothelioma Interest Group. Brescia, Italy. June 20-27, 2004. 19. Refinement and standardization of the VATS lobectomy technique. Annual Techno-College of EACTS/ESTS, Leipzig, Germany, September 13-17, 2004. 20. PET and radiotherapy after resection: The Memorial Sloan-Kettering Experience. IASLC 2004 Mesothelioma Workshop, Ermatingen, Switzerland. September 29-October 2, 2004.

21. Staging of Mesothelioma. First International Symposium on Malignant Mesothelioma. Las Vegas, Nevada, October 14-16, 2004. 22. Laparoscopic surgery in GYN oncology-didactic. Society of Gynecologic Oncologists 36th Annual Meeting, Miami, Florida, March 19-23, 2005.

23. Primary Discussant for Program #48, General Thoracic Surgery Session. American Association of Thoracic Surgery, San Francisco, California, April 10-13, 2005. 24. Decreased PET SUV after induction chemotherapy is associated with improved survival in malignant pleural mesothelioma (MPM). American Society of Clinical Oncology Annual Meeting, Orlando, Florida, May 13-17, 2005. 25. Surgical management of lung cancer. St. Mary’s Hospital, Waterbury, Connecticut, June 15, 2005. 26. Surgical management of malignant pleural mesothelioma. Second International Symposium on Malignant Mesothelioma, Las Vegas, Nevada, October 6-8, 2005. 27. Preoperative staging of mesothelioma. Second International Symposium on Malignant Mesothelioma, Las Vegas, Nevada, October 6-8, 2005. 28. Surgical management of malignant pleural mesothelioma. Colombian Association Of Pulmonology and Thoracic Surgery, Bogota, Colombia, October 13-17, 2005. 29. Surgical management of primary mediastinal germ cell tumors. Colombian Association of Pulmonology and Thoracic Surgery, Bogota, Colombia, October 13-17, 2005.

42

30. Surgical management of pulmonary metastases. Colombian Association Of Pulmonology and Thoracic Surgery, Bogota, Colombia, October 13-17, 2005. 31. VATS lobectomy for early stage lung cancer. Colombian Association Of Pulmonology and Thoracic Surgery, Bogota, Colombia, October 13-17, 2005. 32. Trimodality treatment for lung cancer. American College of Chest Physicians 71st Annual International Scientific Assembly, Montreal, Canada, November 1, 2005. 33. Current status of neoadjuvant therapy and surgery in esophageal cancer. 40th Middle East Medical Assembly, Beirut, Lebanon, May 12, 2006. 34. Role of PET scanning, mediastinoscopy and video-assisted thoracoscopy (VATS) in the diagnosis and management of lung cancer. 40th Middle East Medical Assembly, Beirut, Lebanon, May 13, 2006. 35. Staging algorithms and surgical options in NSCLC. Reality Oncology Lung Cancer – Expanding Your Knowledge: Advancing Your Practice In Lung Cancer, Louisville, Kentucky, June 17, 2006. 36. VATS lobectomy for early stage lung cancer. Monmouth Medical Center Grand Rounds, Monmouth, New Jersey, September 20, 2006. 37. Surgical management of esophageal cancer. Monmouth Medical Center Grand Rounds, Monmouth, New Jersey, September 20, 2006. 38. VATS lobectomy for early staging lung cancer. Frankford Health Systems/PCOM, Grand Rounds, Philadelphia, Pennsylvania, October 3, 2006. 39. The surgical management of esophageal cancer. Systems/PCOM, Grand Rounds, Philadelphia, Pennsylvania, October 3, 2006. 40. Pleural surgical management. Third International Symposium on Malignant Mesothelioma, Chicago, Illinois, October 20, 2006 41. Radiologic imaging. Third International Symposium on Malignant Mesothelioma, Chicago, Illinois, October 21, 2006. 42. Surgery for malignant pleural mesothelioma: A guaranteed complete response Third International Symposium on Malignant Mesothelioma, Chicago, Illinois, October 21, 2006. 43. Debate: There is no role for radical surgery in the management of pleural mesothelioma – Con. International Symposium on Malignant Mesothelioma, Chicago, Illinois, October 21, 2006.

43

44. Surgical treatment for lung cancer. American College of Chest Physicians, Salt Lake City, Utah, October 24, 2006. 45. Keynote Speaker. Medicine for inner city High School students. The Junior Fellows Program The New York Academy of Medicine, New York, New York, November 8, 2006. 46. Surgical issues in thoracic oncology: PET for guidance in surgical management of thoracic tumors. 11th Perspective in Thoracic Oncology Conference, New York, New York, November 18, 2006. 47. Medicine for inner city High School students. Keynote Speaker. Annual Regional Pre- Medical Conference, Cornell University, Weill Medical College, New York, New York, December 9, 2006. 48. The role of VATS in gynecological malignancies. San Diego, California. Society of Gynecologic Oncologists. Postgraduate course. March 24, 2007. 49. The impact of lymph node station on survival in 348 surgically resected malignant pleural mesothelioma (MPM) patients: implications for revision of the AJCC staging system. American Association of Thoracic Surgery. Washington DC, May 7, 2007 50. Extrapleural Pneumonectomy (EPP) versus Pleurectomy/Decortication (P/D) in the surgical management of malignant pleural mesothelioma (MPM): Results in 663 patients. Plenary Session. American Association of Thoracic Surgery. Washington DC, May 8 2007. 51. Multimodality management of malignant pleural mesothelioma. Department of Surgical Oncology Grand Rounds, Fox Chase Cancer Center, Philadelphia, PA. April 24, 2007. 52. VATS Lobectomy, open thoracotomy, and the robot for lung cancer. The Minimally Invasive Thoracic Surgery Summit, The New York Academy of Medicine, New York, NY, June 9, 2007. 53. N.Y. Academy of Medicine. Keynote Speaker. New York, NY October 18, 2007 54. Lung cancer: Advances in surgical management. CancerSmart Lecture Series, Memorial Sloan-Kettering Cancer Center, New York, NY, October 23, 2007 55. Robotic Lobectomy for Early Stage Lung Cancer. Primary Discussant – 54th Annual of Southern Thoracic Surgical Association, Bonita Springs, Florida. November 8, 2007. 56. Minimally Invasive Approaches to major pulmonary resection. University of Massachusetts, Worchester, MA December 10, 2007.

44

57. VATS Lobectomy/Segmentectomy versus Thoracotomy for Lung Cancer. General Thoracic Surgical Forum, Japan, Tokyo. February 16, 2008 58. Extrapleural Pneumonectomy vs. Pleurectomy Decortication. International Mesothelioma Program. Boston, MA. April 10-11, 2008 59. Oncologic Efficacy of Thoracoscopic Lobectomy. VATS Lobectomy course for Covidien (US Surgical). Miami, Florida. April 17-18, 2008 60. Malignant Mesothelioma-Current Approaches to a Difficult Problem. American Association for Thoracic Surgery 88th Annual Meeting. San Diego, CA. May 10-14, 2008.

61. VATS Lobectomy Versus Thoracotomy for Lung Cancer – Results in 741 Patients. American Association for Thoracic Surgery 88th Annual Meeting. San Diego, CA. May 10-14, 2008.

62. Lecture on “Role of PET” in the session on “Staging”. Surgery-Based multimodality therapy for malignant pleural mesothelioma Symposium. Dallas, Texas. June 13, 2008.

63. Malignant Pleural Mesothelioma: Pleurectomy versus EPP. 16th European Conference on General Thoracic Surgery. Bologna, Italy. June 11, 2008.

64. Oesophagectomy for Resectable Cancer: Minimally invasive versus open. 16th European Conference on General Thoracic Surgery. Bologna, Italy. June 9, 2008.

65. Multimodality Treatment of Malignant Pleural Mesothelioma. Pulmonary Conference. Philadelphia, PA. June 24, 2008.

66. Pleural Meso Surgical Options. International Symposium on Malignant Mesothelioma 2008. Washington, DC. June 27, 2008.

67. Mesothelioma: Past and Present. New Approaches in the Diagnosis & Treatment of Lung Cancer 8th Annual Meeting. Cincinnati, OH. September 12-13, 2008. 68. Pleurectomy. Session IV – Mesothelioma. Science of Thoracic Surgery 20th Anniversary Course. Boston, MA. October 3, 2008. 69. VATS Lobectomy versus Thoracotomy for Lung Cancer. Session II: Lung Cancer and its Treatment. Northeast Thoracic Summit (NETS) Uncasville, CT. October 4, 2008. 70. Surgical Treatment of Mesothelioma Extrapleural Pneumonectomy versus Pleurectomy/ Decortication for Malignant Pleural Mesothelioma. Session II: Lung Cancer and its Treatment. Northeast Thoracic Summit (NETS) Uncasville, CT. October 4, 2008. 71. Quality of Life Outcomes. Video Assisted Thoracic Surgery (VATS) Mini-Fellowship. Henderson, Nevada October 30, 2008

45

72. Keynote – Mentoring. Annual Regional Pre-Medical Conference. Weill Cornell Medical College SEOM/SNMA/BLHO New York, NY December 13, 2008

73. Combined Modality Therapy for Malignant Pleural Mesothelioma. 1st Annual Thoracic Oncology Conference. Philadelphia, PA January 23, 2009

74. VATS Lobectomy vs Thoracotomy for Lung Cancer. John Jones Surgical Society 9th Spring Meeting. Columbia University Medical Center & New York-Presbyterian Hospital, New York, NY May 8, 2009. 75. Chairman: Thoracic Developmental Skills. VATS Lobectomy: Technical Details of All Five Lobes. 89th Annual Meeting of the American Association for Thoracic Surgery. Boston, MA. May 9, 2009. 76. Multimodality Treatment of Malignant Pleural Mesothelioma. 62ème Congrès de la Sociètè Française de Chirurgie Thoracique et Cardio-Vasculaire. Lille Grand Palais, Lille, France June 10-13, 2009 77. New Insights in the Pathogenesis and Treatment of Malignant Mesothelioma. Co-Chair. International Association for the study of lung cancer (IASLC). Orlando, FL. August 1, 2009 78. Surgical Management of Malignant Pleural Effusions. International Association for the study of lung cancer (IASLC). Orlando, FL. August 2, 2009. 79. Fissure Last: Posterior Straight Stapler. VATS Lobectomy Mini-Fellowship. Roswell Park Cancer Institute. Buffalo, NY September 24-25. 2009 80. Junior Fellows Induction Ceremony. New York Academy of Medicine. New York, NY. November 19, 2009. 81. Malignant Pleural Mesothelioma – Multimodality Management with an Emphasis on Surgery. Cornell Surgical Grand Rounds. New York Hospital. New York, NY. March 1, 2010 82. Patterns of Recurrence and Incidence of Second Primary Tumors After Lobectomy by VATS Versus Thoracotomy for Lung Cancer. AATS Annual Meeting. Toronto, Canada. May 3, 2010. 83. Presente y Futuro de las Resecciones Robóticas/ State-of-the-Art in Robotic Resections. I Congreso de la Sociedad Española de Cirugía Torácica. (SECT). Málaga, Spain. May 6, 2010 84. Cirugía radical. EPP/ Radical Surgery. Extrapleural Pneumonectomy. I Congreso de la Sociedad Española de Cirugía Torácica. (SECT). Málaga, Spain. May 7, 2010

46

85. Management of Sarcoma Patients with Lung Metastasis – Minimally Invasive/Non- Resection Approaches. ASCO, Chicago, Ill. June 6, 2010 86. Update in Mesothelioma Therapy. National Corporate Medical Associates 27th

Annual Education Conference 2010, Memorial Sloan-Kettering Cancer Center, New York, NY. June 16, 2010. 87. Changing Trends in the Surgical Management of Mesothelioma. 66th Annual Tri-State Thoracic Conference. Egg Harbor, WI. September 12, 2010. 88. Malignant Pleural Mesothelioma – Changing Trends in Surgical Management. Montefiore Medical Center. New York, NY. October 18, 2010. 89. VATS Lobectomy: The Evidence. 23rd International Conference on Screening For Lung Cancer. New York, NY. October 22, 2010. 90. Adjuvant and Neoadjuvant Chemotherapy in Traditional Resectable Tumors. The Third Annual Northeast Thoracic Summit. New York, NY. October 23, 2010. 91. Technical Details of VATS Right Upper and Left Upper Lobectomy and Lymph Node Dissection. VATS Lobectomy and Segmentectomy, Interactive Web Symposium. Clevaland, OH. October 29, 2010. 92. Mesothelioma: Changing Trends in Surgical Management. Department of Preventive Medicine Grand Rounds, Mount Sinai Medical Center. New York, NY. November 19, 2010. 93. Advanced Techniques and Tricks of VATS Lobectomy. New York Society of Thoracic Surgery. New York, NY. November 20, 2010. 94. Chairman, Multimodality Treatment of Esophageal and Gastric Malignancies. Memorial Sloan-Kettering Cancer Center. New York, NY. 95. VATS Lobectomy: Technique. 59th Annual Clinical Meeting of the American College of Surgeons – New Jersey Chapter. Iselin, NJ. December 4, 2010. 96. Mesothelioma. Surgical Grand Rounds. Lutheran Medical Center. Brooklyn, NY. January 20, 2011 97. VATS Lobectomy: Improved Patient Outcomes at a Reduced Costs. 47th Annual Meeting, Society of Thoracic Surgeons. San Diego, CA. January 31, 2011. 98. Unnecessary Surgery. 24th International Conference on Screening for Lung Cancer. Scottsdale, AZ. February 25, 2011.

47

99. Mesothelioma. Surgical Grand Rounds, Mount Sinai Medical Center. New York, NY. March 9, 2011 100. Mesothelioma. 7th Annual Asbestos Awareness Conference. Atlanta, GA. April 2, 2011 101. VATS Lobectomy: Catastrophic Intraoperative Complications. 91st Annual American Association for Thoracic Surgery Conference. Philadelphia, PA. May 10, 2011. 102. Surgical Management of Malignant Pleural Mesothelioma. Surgical Grand Rounds, St. Luke’s-Roosevelt Hospital Center. New York, NY. May 25, 2011. 103. Comparison and Review of Lobectomy Dissection Order and Sealing Technologies: Thoracoscopic Approaches. International Society for Minimally Invasive Cardiothoracic Surgery, Postgraduate Course, Thoracic Surgery. Washington, DC. June 8, 2011. 104. VATS Lobectomy for Lung Cancer: Technique and Outcome. 5th China Lung Cancer Minimally Invasive Treatment Forum. Guangzhou, China. June 25, 2011. 105. Live surgery performance. 2nd Asian-Pacific VATS Lobectomy Live Performance. Guangzhou, China. June 25, 2011. 106. Key Note Speaker. Mount Sinai School of Medicine White Coat Ceremony. New York, NY. September 12, 2011. 107. Mesothelioma. Pulmonary Care Grand Rounds. Mount Sinai Medical Center, New York, NY. September 23, 2011. 108. Address to the Einstein Class of 2015. Albert Einstein School of Medicine, Bronx, NY. October 5, 2011. 109. Surgical Treatment of Early Stage Disease: VATS and Limited Resections. Dutch Refresher Course. Mount Sinai Medical Center, New York, NY. October 7, 2011. 110. Surgical Options for Small Nodules. New York Radiology Society Annual Meeting, New York, NY. October 14, 2011. 111. The Nonsolid Nodule: Surgical Treatment. Teleconference Presentation 25th International Conference of Screening for Lung Cancer, Hadassah Medical Organization, Jerusalem, Israel, October 25, 2011. 112. The Junior Fellows Induction Ceremony. Keynote Address, New York Academy of Medicine. New York, NY. November 1, 2011.

48

113. Tecnica de la Lobectomia y Diseccion Ganglionar Por Vats. XIX Congreso Iberoamericano de Cirugia de Torax, XVII Congreso Nacional de Neumologia, Guayaquil, Ecuador, November 11, 2011. (presentation given in Spanish) 114. Patrones de Recurrencia e Incidencia en Segundos Tumores Primarios: VATS vs Toracotomia. XIX Congreso Iberoamericano de Cirugia de Torax, XVII Congreso Nacional de Neumologia, Guayaquil, Ecuador, November 11, 2011. (presentation given in Spanish) 115. Lobectomia por Ca: Supervivencia en Cirugia por VATS vs Toracotomia. XIX Congreso Iberoamericano de Cirugia de Torax, XVII Congreso Nacional de Neumologia, Guayaquil, Ecuador, November 11, 2011. (presentation given in Spanish) 116. Complicaciones Catastroficas Intraoperatorias de la Lobectomia VATS. XIX Congreso Iberoamericano de Cirugia de Torax, XVII Congreso Nacional de Neumologia, Guayaquil, Ecuador, November 11, 2011. (presentation given in Spanish) 117. Mesothelioma. Good Samaritan Hospital, Long Island, NY, December 15, 2011. 118. Current Management of Mesothleioma. 30th Annual Symposium Clinical Update in Anesthesiology, Surgery and Perioperative Medicine, Rio Grande, Puerto Rico, January 17, 2012. 119. Keynote Presentation. Miles for Meso Symposium. Boca Raton, Florida, February 11, 2012. 120. Mesothelioma. Basic Science Lecture, Mount Sinai School of Medicine, New York, NY, March 8, 2012. 121. Mesothelioma. Health Evidence and Policy Grand Rounds, Mount Sinai School of Medicine, New York, NY, April 3, 2012. 122. Harms of Screening: Can they be Reduced? Surgery. 26th International Conference On Screening for Lung Cancer. Miami, Florida, April 16, 2012. 123. Care of the Postpneumonectomy Patient. 92nd Annual Meeting of the American Association of Thoracic Surgery. San Francisco, California, April 28, 2012. 124. Surgery for Malignant Pleural Mesothelioma. 2012 Insulators Medical Conference. Washington, D.C., May 3, 2012.

49

125. Surgical Management of Malignant Pleural Mesothelioma: Still Evolving. 2nd International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma. Los Angeles, California, May 12, 2012. 126. New Surgical Techniques for Lung Cancer. Montefiore Medical Center, The Albert Einstein College of Medicine, Lung Cancer Preceptorship Program. New York, NY, May 24, 2012. 127. New Surgical Techniques for Lung Cancer. University of Miami, Miami, Fl. June 21, 2012. 128. Demystifying Scientific Breakthroughs. Mesothelioma Applied Research Foundation Symposium 2012, Washington, D.C. July 12, 2012. 129. Surgical Management of Malignant Pleural Mesothelioma. Visiting Professor, Henry Ford Hospital, Detroit, MI. July 28, 2012. 130. Assessment of the Solitary Pulmonary Nodule. Cardiotrax 2012, III Biennial Course of the Hospital Aleman, Buenos Aires, Argentina, August 30-31, 2012. 131. How Do I Do It: VATS Lobectomy, troubleshooting. Cardiotrax 2012, III Biennial Course of the Hospital Aleman, Buenos Aires, Argentina, August 30-31, 2012. 132. Trimodality Treatment for Pancoast Tumors: Results & Outcomes. Cardiotrax 2012, III Biennial Course of the Hospital Aleman, Buenos Aires, Argentina, August 30-31, 2012. 133. Updates in MPM. Cardiotrax 2012, III Biennial Course of the Hospital Aleman Buenos Aires, Argentina, August 30-31, 2012. 134. Surgical Options (Pleurodesis vs. Extended Pleurectomy/Decortication) EPP. Cardiotrax 2012, III Biennial Course of the Hospital Aleman, Buenos Aires, Argentina, August 30-31, 2012. 135. Mediastinal Tumors: Evaluation, Staging and Surgical Treatment. Cardiotrax 2012, III Biennial Course of the Hospital Aleman Buenos Aires, Argentina, August 30-31, 2012. 136. Chair – General Session III: Surgical Treatments. International Mesothelioma Interest Group (iMig) 2012 Conference. Boston, MA. September 13, 2012. 137. Thoracoscopic Lobectomy. European Society of Thoracic Surgeons. ESTS School Of Thoracic Surgery, Elancourt, France, September 24-25, 2012. 138. Thoracoscopic Segmentectomy. European Society of Thoracic Surgeons. ESTS School Of Thoracic Surgery, Elancourt, France, September 24-25, 2012.

50

139. Surgical Approach to Dumbbell Neurogenic Tumors of the Posterior Mediastinum. European Society of Thoracic Surgeons. ESTS School Of Thoracic Surgery, Elancourt, France, September 24-25, 2012. 140. Address to the Einstein Class of 2016. Albert Einstein School of Medicine, Bronx, NY. October 3, 2012. 141. Surgical Treatment of Early Stage Disease: VATS and Limited Resections. Dutch Refresher Course, Mount Sinai School of Medicine, New York, NY October 9, 2012. 142. Overestimation from the Harms of Surgery. 27th International Conference on Screening for Lung Cancer Mount Sinai School of Medicine, New York, NY November 4, 2012. 143. Surgical Management of Lung Cancers Manifesting as Nonsolid Nodules. 27th International Conference on Screening for Lung Cancer Mount Sinai School of Medicine, New York, NY November 5, 2012. 144. Which Operation? Second International Joint Meeting on Thoracic Surgery, Barcelona, Spain, November 14, 2012. 145. VATS Segmentectomy. Second International Joint Meeting on Thoracic Surgery, Barcelona, Spain, November 14, 2012. 146. How To Do It By VATS. Second International Joint Meeting on Thoracic Surgery, Barcelona, Spain, November 15, 2012. 147. Chairperson – Surgical Techniques for Advanced Thoracic Malignancies. Second International Joint Meeting on Thoracic Surgery, Barcelona, Spain, November 16, 2012. 148. Mesothelioma Overview: Magnitude of the Problem. Second International Joint Meeting on Thoracic Surgery, Barcelona, Spain, November 16, 2012. 149. Screening for Lung Cancer. Department of Medicine Grand Rounds, Mount Sinai Medical Center, New York, NY, December 4, 2012. 150. Surgical Approaches to Pulmonary Metastasis. 29th Annual New York, Controversies, Problems and Techniques in Surgery, New York, NY, December 15, 2012. 151. Current Management of Mesothelioma. 31st Annual Symposium: Clinical Update in Anesthsiology, Surgery and Perioperative Medicine, Curacao, January 22, 2013. 152. STE, Cirugia de la Hiperhidrosis. Aspectos controversiales, Cancer de Pulmon. Indicaciones de cirugia y seleccion de la via abordaje, Tecnica quirurgica. Detalles de tecnica segum Mount Sinai Medical Center. Centro Nacional deCirugia de Minimo

51

Acceso, Havana, Cuba, February 25, 2013. 153. Live Surgery Performance. Centro Nacional deCirugia de Minimo Acceso, Havana, Cuba, February 25, 2013. 154. Videothoracic Anatomical Resection: How I Do It. Experts’ Meeting: Videoconference From “Ospedale San Paolo”, Bari, Italy, March 6, 2013. 155. Early Detection and New Treatment Modalities for Lung Cancer. Medical Education Seminar, St. Luke’s Cornwall Hospital, Newburgh, NY, June 1, 2013. 156. Surgical Management of Malignant Pleural Mesothelioma. Beck Lecture in Thoracic Surgery, UHCMC Department of Surgery Grand Rounds, Cleveland, OH, June 15, 2013 157. Thoracic Surgery for Lung Cancer. 9th Annual Challenges in Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, June 20, 2013. 158. Mesothelioma. 2nd Annual Meso Foundation NY Regional Chapter, New York, NY, September 27, 2013. 159. Libby Amphibole Exposure. 29th International Conference on Screening for Lung Cancer New York, NY, October 13, 2013. 160. Resultados a largo plazo en CPCNP tratado con cirugía mínimamente invasiva (VATS y

robótica) vs el enfoque clásico: sobrevida libre de enfermedad y sobrevida global Simposio Latinamericano de Oncologia Toracica. Santiago, Chile, November 14, 2013.

161. Rol de la cirugía en el CPNCP en etapas avanzadas de la enfermedad: ¿hay algún avance

en esta nueva era del conocimiento? Simposio Latinamericano de Oncologia Toracica. Santiago, Chile, November 14, 2013

162. Tips quirúrgicos avanzados para lobectomía por VATS: como mantener una tasa

de conversión bajo 5% manteniendo un alto estándar oncológico. Simposio Latinamericano de Oncologia Toracica. Santiago, Chile, November 15, 2013.

163. El futuro de la cirugía oncológica torácica: el camino de la tecnología, la genética y las

células madre vivirán por siempre. Simposio Latinamericano de Oncologia Toracica. Santiago, Chile, November 14, 2013. 164. Left Upper lobectomy: How I do it. Advanced Course in Thoracoscopic Procedures, IRCAD, Strasbourg, France, November 21-23, 2013. 165. Segmentectomies: How I do it. Advanced Course in Thoracoscopic Procedures, IRCAD, Strasbourg, France, November 21-23, 2013.

52

166. Troubleshooting, my complications: How Many? What Did Occur? How I Did Manage It? Which Lesson? Advanced Course in Thoracoscopic Procedures, IRCAD, Strasbourg, France, November 21-23, 2013.

167. Advanced Techniques: Sleeve Lobectomies. Advanced Course in Thoracoscopic

Procedures, IRCAD, Strasbourg, France, November 21-23, 2013. 168. Panel Discussion – Controversies in CT Nodule Management. Society of Thoracic Surgery 50th Annual Meeting, Orlando, F, January 27, 2014.

169. Moderator – Patient Safety Symposium. Society of Thoracic Surgery 50th Annual Meeting, Orlando, FL, January 28, 2014. 170. Challenges in VATS Lobectomy. Society of Thoracic Surgery 50th Annual Meeting, Orlando, FL, Tuesday, January 28, 2014. 171. Modern conception in managing pneuthorax. III Encuentro Cubano De Cirugia Toracicica Infinimamente Invasive, Hospital 10 de Octubre

Havana, Cuba, February 5, 2014. 172. VATS lobectomy for tumor. III Encuentro Cubano De Cirugia Toracicica Infinimamente Aceso, Hospital 10 de Octubre

Havana, Cuba, February 5, 2014. 173. Live surgical performance. Hospital 10 de Octubre Havana, Cuba,

February 4, 5, 6, 2014. 174. Surgery for mesothelioma, state-of-the-art. University of Hawaii Cancer Center, Honolulu, HI, February 22, 2014. 175. The role of decortication in mesothelioma. General Thoracic Surgical Club, Litchfield Park, AZ, March 14, 2014. 176. Which patients with primary lung cancer should receive which resection? 2014 World Conference of Interventional Oncology, New York, NY, May 13, 2014. 177. Current management of mesothelioma. Invited Templeton Lecture, Jefferson University Physicians, Philadelphia, PA, May 22, 2014. 178. Lung Cancer. 10th Annual Challenges in Internal Medicine: Closing the Gap in

Primary Care, Icahn School of Medicine at Mount Sinai, New York, NY, June 19, 2014.

179. Libby Epidemiology Research Program (LERP) meeting. Center for Asbestos Related Disease (CARD), Libby, Montana, July 9-11, 2014.

53

180. Lung Cancer and Surgery, National Center of Minimal Invasive Surgery, Havana, Cuba March 3-4, 2015. 181. Live surgical performance. Hospital 10 de Octubre Havana, Cuba, March 2-3, 2015. 182. Libby Panel - Broader Field of Public Health ADAO's 11th Annual International

Asbestos Awareness Conference, Washington, DC, April 16-18, 2015.

183. Discussant, General Thoracic Surgery Simultaneous Scientific Session, American Association of Thoracic Surgery, Seattle, Washington, April 26-28, 2015.

184. Thoracic Surgery, LUNGevity 5th Annual HOPE Summit, Washington, DC, May 2, 2015. 185. Surgery Strategies for Pulmonary Reservation, VI SECT Congress, Seville, Spain, May 12-16, 2015. 186. Pros and Cons of lung cancer screening: Multicenter trial NLST, VI SECT Congress, Seville, Spain, May 12-16, 2015. 187. Thoracic Traumatism in NYC, VI SECT Congress, Seville, Spain, May 12-16, 2015. 188. Minimally Invasive Surgery, VI SECT Congress, Seville, Spain, May 12-16, 2015. 189. Mesothelioma - The Magnitude of the Worldwide Asbestos Problem,

Libby Amphibole Symposium, Spokane, Washington, May 27, 2015. 190. Discussant at the Brompton Session, 23rd European Conference of General

Thoracic Surgery, June 1-3, 2015.

191. Surgical & Other Interventions, 3rd Annual International Association for the Study of Lung Cancer (IASLC), Denver, Colorado, September 5, 2015. 192. What is the Role of Surgical Resection in the Setting of Multiple GGO’s? World Conference on Lung Cancer, Denver, Colorado, September 7, 2015. 193. Surgical Management of Malignant Pleural Mesothelioma. 2ª Jornadas de Oncologia Toracica del Cono Sur, Montevideo, Uruguay, October 21-25, 2015. 194. What Have We Learned From the Past 20 Years? Advances in Pleural Mesothelioma, London, England, November 6-7, 2015. 195. Extended VATS Lobectomy, 3rd International Joint Meeting on Thoracic Surgery, Barcelona, Spain, November 18-20, 2015.

54

196. Lymphadenectomy by VATS, 3rd International Joint Meeting on Thoracic Surgery, Barcelona, Spain, November 18-20, 2015. 197. Which Surgery for Each Patient? 3rd International Joint Meeting on Thoracic Surgery, Barcelona, Spain, November 18-20, 2015. 198. Thoracic Surgery in the 21st Century: Is There Light at the End of the Tunnel? 69th Post Graduate Assembly in Anesthesiology, New York, New York, December 13, 2015. 199. Indications for Sublobar Resection. European Society of Thoracic Surgeons at 52nd Annual Meeting of the Society of Thoracic Surgeons: Controversial Issues in General Thoracic Surgery—Perspectives from Europe and North America, Phoenix, Arizona, January 23-27, 2016. 200. Surgical Treatment of Locally Advanced Lung Cancer (T4): What is the Limit? 75 Congress of Pneumology and Thoracic Surgery, Guadalajara, Mexico, March 28-30, 2016. 201. Indications for Sublobar Resection. 75 Congress of Pneumology and Thoracic Surgery, Guadalajara, Mexico, March 28-30, 2016. 202. How to Avoid VATS Complications. 75 Congress of Pneumology and Thoracic Surgery, Guadalajara, Mexico, March 28-30, 2016. 203. Surgical Treatment of Mesothelioma. 75 Congress of Pneumology and Thoracic Surgery, Guadalajara, Mexico, March 28-30, 2016. 204. Surgical Advancements and Challenges in Treating Mesothelioma. 12th Annual Asbestos Disease Awareness Organization (ADAO) International Asbestos Awareness and Awareness Conference, Washington, DC, April 9, 2016. 205. What Would You Do First in Early Stage MPM – Surgery or Chemotherapy? 13th International Conference of the International Mesothelioma Interest Group, Birmingham, UK, May 1-4, 2016. 206. The Role of Pleurectomy/Decortication in the Mesothelioma Risk-Benefit Equation. 13th International Conference of the International Mesothelioma Interest Group, Birmingham, UK, May 1-4, 2016. 207. Role of VATS Lobectomy for Locoregionally Advanced NSCLC. American Association of Thoracic Surgery 96th Annual Meeting, Baltimore, MD, May 15, 2016. 208. After Lung Screening: Where Do We Go From Here? Men’s Health & Cancer Awareness Symposium, Mount Sinai Health System, New York, NY, June 17, 2016.

55

209. Management of Malignant Pleural Mesothelioma. Grand Rounds, Division of Occupational Medicine, Icahn School of Medicine, Mount Sinai Health System, New York, NY July 8, 2016. 210. Open versus VATS Lobectomy. V Congreso Sociedad Mexicana Cirujanos Toracicos Generales, Mexico City, Mexico September 29, 2016. 211. Thymus Surgery Experience at Mount Sinai. V Congreso Sociedad Mexicana Cirujanos Toracicos Generales, Mexico City, Mexico, September 29, 2016. 212. Mesothelioma Surgery. Sociedad Mexicana V Congreso Cirujanos Toracicos Generales, Mexico City, Mexico, September 29, 2016. 213. Management of Ground Glass Opacities. V Congreso Sociedad Mexicana Cirujanos Toracicos Generales, Mexico City, Mexico, September 30, 2016. 214. Sublobar Resection for Lung Cancer: An Oncologically Sound Procedure. Eastern Cardiothoracic Surgical Society Meeting, St. Pete’s Beach, FL October 22, 2016. 215. Sub-solid Nodules: Considerations for “Watchful waiting”. 35th International Conference on Screening for Lung Cancer. New York, NY November 18, 2016. 216. Present and Future of Esophageal Surgery. 70th Post Graduate Assembly in Anesthesia New York, NY December 11, 2016. 217. Lung Cancer – Screening. 35th Annual International Symposium: Clinic Update in Anesthesiology, Surgery and Perioperative Medicine. Cancun, Mexico January 17, 2017. 218. Moderator - Medical Advancements: Diagnosing and Treating Mesothelioma and Other Asbestos-Related Diseases. 13th Annual International ADAO Asbestos Awareness and Prevention Conference Arlington, Virginia April 8, 2017. 219. Lung Cancer 101. 7th Annual LUNGevity National Hope Summit. Arlington, Virginia April 29, 2017. 220. Evidence Review of Best Strategy for Classic Presentation of Malignant Mesothelioma AATS/STS General Thoracic Surgery Symposium: Thoracic Surgery 2017 - State of the Art Boston, Massachusetts April 30, 2017. 221. Multiportal Vats (teleconference). Humanitas Cancer Center Workshop Future Perspectives in Minimally Invasive Lung Sparing Surgery. Milan, Italy May 11, 2017. 222. Why I Do Vats (teleconference). Humanitas Cancer Center Workshop Future Perspectives in Minimally Invasive Lung Sparing Surgery. Milan, Italy May 11, 2017.

56

223. CT Screening for Lung Cancer: What is the true benefit? RJ Ginsberg Lecture 43rd Annual Toronto Thoracic Surgery Refresher Course, University of Toronto, Canada June 2-3, 2017. 224. Complications during VATS lobectomy. 43rd Annual Toronto Thoracic Surgery Refresher Course, University of Toronto, Canada June 2-3, 2017. 225. Major Procedure in Thoracic Surgery. Brazilian Thoracic Surgery Society- Thoracic Oncology Symposium, Rio de Janeiro, Brazil June 30 – July 1, 2017. 226. Sublobar Resection for Lung Cancer. Brazilian Thoracic Surgery Society- Thoracic Oncology Symposium, Rio de Janeiro, Brazil June 30 – July 1, 2017. 227. Debate: Resection of N2+ Lung Cancer. Brazilian Thoracic Surgery Society- Thoracic Oncology Symposium, Rio de Janeiro, Brazil June 30 – July 1, 2017. 228. Thoracic Surgeon on Pulmonary Nodules. Latin American Forum 2017, Orlando, Florida, August 26, 2017. 229. Complications Related to Pulmonary Nodules Surgical Treatment. Latin American Forum 2017, Orlando, Florida, August 26, 2017. 230. IASL/ITMIG – Proposing TNM Staging of Thymic Malignancies, Surgical Implications and Prognosis. Latin American Forum 2017, Orlando, Florida, August 26, 2017. 231. CON: RATS Approach. Surgical Implications and Prognosis. Latin American Forum 2017, Orlando, Florida, August 26, 2017. 232. Moderator – Radiomics, blood tests and other considerations. 37th International Conference on Screening for Lung Cancer and 5th Conference on Research for Early Lung Cancer Treatment, Seattle, Washington September 15-16, 2017. 233. Challenges Facing the Thoracic Surgeon. Dutch Refresher Course 2017, Icahn School of Medicine at Mount Sinai, New York, NY, October 4, 2017. 234. Complications in VATS Surgery. IV International Workshop on Thoracic Video Assisted Surgery. Havana, Cuba October 19-21, 2017. 235. Management of Mediastinal Masses. IV International Workshop on Thoracic Video Assisted Surgery. Havana, Cuba October 19-21, 2017. 236. Staging of Lung Cancer. IV International Workshop on Thoracic Video Assisted

Surgery. Havana, Cuba October 19-21, 2017.

57

237. Early Lung Cancer Detection. IV International Workshop on Thoracic Video Assisted Surgery. Havana, Cuba October 19-21, 2017. 238. Lung cancer screening using low-dose computed tomography scans: Why we should do it? ISMICS Winter Workshops, Abu Dhabi, United Arab Emeritus, December 8-9, 2017. 239. Extended VATS lobectomy: where is the limit? ISMICS Winter Workshops, Abu Dhabi, United Arab Emeritus, December 8-9, 2017. 240. Esophageal Tumors. Icahn School of Medicine at Mount Sinai, New York, NY February 2, 2018. 241. Lung Cancer Screening. Icahn School of Medicine at Mount Sinai, New York, NY March 6, 2018. 242. Continuing Dr. Irving Selikoff’s Lifetime Legacy, As Clinicians and Advocates. ADAO’s 14th Annual International Asbestos Awareness and Prevention Conference, “Where Knowledge and Action Unite,” on April 13 – 15, 2018 in Washington, DC. 243. Malignant Mesothelioma. Oncology Teaching Day, Vassar Brothers Medical Center Poughkeepsie, NY May 16, 2018. 244. Group Discussion-Case Based, Lung Cancer: Stage 0 & 1. Case Discussion-Local

Advanced Disease: Complex Ressections-Artery and Group Discussion-Oligometastasis. Latin American Forum Masters sponsored by Johnson & Johnson. Raynham, MA, August 27-29, 2018.

245. Mesothelioma Applied Research Foundation. International Symposium in Malignant Mesothelioma. Pleural Surgery – Do’s and Don’ts. Marriott New York East Side,

New York, NY, October 5, 2018. 246. 39th International Conference on Screening for Lung Cancer & 7th Conference on Research

for Early Lung Cancer Treatment. Culinary Institute of America, Hyde Park, NY, October 16-17, 2018.

247. Memorial Hospital Alumni Society. Esophagogastric Cancer: Incorporating Science into

Multimodality Clinical Care. Personalized Approach to Perioperative Therapy and Surgery: Surgical Management of Advanced GEJ Cancer, New York, NY, October 18, 2018.

248. Instituto Nacional de Cancerologia. Master Class CPCNP. Methods, indications and

requirements for an optimal biopsy in the diagnosis of CPCNP. Indications and recommendations for an optimal surgical biopsy 20’. Tlalpan, Ciudad de Mexico, November 5-6, 2018.

58

249. Instituto Nacional de Cancerologia. Master Class CPCNP. Approach, Diagnosis and treatment of patient with the use of progressive inhibitors of TK. Second Biopsy: What it is? Why is it needed and what is the outcome of performing it? Tlalpan, Ciudad de Mexico, November 5-6, 2018.

59

Marital Status: Married Spouse’s Name: Kathryn Q. Flores, M.D. Dependents #: 3 (Isabella, Kaitlin, Harry) Military Service: JROTC